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Summary 
 
Pneumonia is the greatest single cause of mortality in children less than five years of age 
throughout the world causing more deaths than those due to AIDS, malaria and tuberculosis 
combined. Approximately 50% of all childhood pneumonia deaths occur in sub-Saharan Africa. 
Children in developing countries being treated for pneumonia frequently have one or more 
comorbid conditions which increases their risk of dying.  The proper management of the child with 
severe or very severe pneumonia is essential to reduce case fatality.  Standard case management 
(SCM) of pneumonia, has been shown to be an effective intervention to reduce deaths from 
pneumonia, but what is lacking is a means of delivering it in low-resource/high burden countries.   
 
A major barrier to wide application of this intervention in low-income countries is weak health-care 
systems with insufficient human and financial resources for implementing SCM to a sufficient 
number of children at a level of quality and coverage that would result in a significant impact. The 
objective of this dissertation is to address this issue by investigating ways of improving delivery of 
standard case management of pneumonia in district hospitals throughout Malawi, a high HIV-
prevalent country which would result in a decrease in the in-hospital case fatality rates (CFR) from 
pneumonia in children less than five years of age. 
 
We reviewed the evidence base for SCM.  Then we evaluated the development and 
implementation of a national Child Lung Health Programme (CLHP) to deliver SCM of severe and 
very severe pneumonia and a programme to provide uninterrupted oxygen supply in all paediatric 
wards at District Hospitals throughout Malawi.  We demonstrated that it was feasible to implement 
and maintain both programmes country-wide. 
 
Thirdly we evaluated the trend in case fatality rates in infants and young children (0 to 59 months 
of age) hospitalized and treated for severe and very severe pneumonia over the course of the 
implementation of the CLHP.  The findings from this study showed that in the majority (64%) of 
cases, who were aged 2-59 months with severe pneumonia there was a significant effect of the 
intervention that was sustained over time whereas in the same age group children treated for very 
severe pneumonia there was no interventional benefit. No benefit was observed for neonates. 
 
Fourthly we investigated factors associated with poor outcome reported in the previous study, in a 
subset of this cohort to determine the individual factors including demographics of the study 
population, recognised co-morbidities and clinical management that were associated with inpatient 
death.  This study identified a number of factors associated with poor pneumonia-related outcomes 
in young infants and children with very severe pneumonia.  They included co-morbidities of 
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malaria, malnutrition, severe anaemia and HIV infection. The study found that the majority of 
reported comorbid conditions were based on clinical signs alone indicating a need for more 
accurate diagnosis and improved management of these comorbidities that may lead to improved 
outcomes. Other identified factors included a number of potentially modifiable aspects of care 
where adjustments to the implementation of SCM are indicated.  These included enhancing correct 
classification of the severity of the disease, the use of correct antibiotics according to standard 
case management, more extensive availability and use of oxygen together with oximetry to guide 
its use,. 
 
Finally recommendations were made to address the identified reasons for poor outcomes and 
suggested future research. 
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Opsomming 
 
Pneumonie is die grootste enkele oorsaak van sterftes by kinders jonger as 5 jaar in die wêreld en 
veroorsaak meer kindersterftes as die menslike immuungebrekvirus (MIV), malaria en tuberkulose 
saam. Ongeveer 50% van kindersteftes van pneumonie kom in sub-Sahara-Afrika voor. Kinders in 
ontwikkilende lande, wie vir pneumonie behandel word, het dikwels een of meer bydraende 
toestande wat die doodsrisiko verhoog.  Kinders wie ernstige of baie ernstige pneumonie 
onderlede het moet korrek behandel word om sterfte te voorkom. Die standaard protokolle om 
kinderpneumonie korrek te behandel het getoon om effektief te wees om die sterftesyfers te 
verlaag. In lae inkomste lande bestaan die strategieë nie om die protokolle aan te wend nie.  
 
‘n Groot struikelblok in die aanwending van die pneumonie behandelingsprotokolle in lae-inkomste 
lande is die swak gesondheidsorgsisteme met onvoldoende menslike en finansiële hulpbronne. 
Die tekorte gee aanleiding tot die beperkte implementering van pneumonie protokolle wat die 
omvang en kwaliteit van die pneumonie protokolle beperk en daarom impakteer die protokolle nie 
op die kindersterftesyfer nie. Die doel van die verhandeling is om hierdie probleem aan te spreek 
deur navorsing hoe om die pneumonie protokolle landwyd in alle distrikhospitale in Malawi, ‘n land 
met ‘n hoë MIV prevalensie, aan te wend om sodoende die kindersterftesyfer (kinders jonger as 5 
jaar) as gevolg van pneumonie te verlaag. 
 
Ons het die getuienis van die pneumonie protokolle ondersoek. Hierna is ‘n nasionale Kinderlong 
Gesondheidsprogram ontwikkel en landwyd geïmplementeer. Volgens die program is kinders met 
ernstige en baie ernstige pneumonie volgens Wêreldgesondheidsorganisasie (WGO) protokolle 
behandel.  Ononderbroke suurstoftoevoer in alle pediatriesesale in distrikshospitale in Malawi 
veskaf. Die navorsing het getoon dat die implementering en instandhouding van pneumonie 
behandelingsprotokolle is landwyd moontlik.  
 
Verder het ons die tendens ondersoek of die kindersterftesyfer in babas en jong kinders (0 tot 59 
maande) wat in die hospital opgeneem en behandel is vir ernstige en baie ernstige pneumonie 
tydens die implementering van pneumonie protokolle verminder het.  Die bevindinge van hierdie 
verhandeling wys dat in die meerderheid (64%) van die kinders tussen 2 en 59 maande met 
ernstige pneumonie, en met die toepassing van die pneumonie protokolle, statistiesbetekenvol die 
sterfte syfer verlaag het. Die protokolle vir die behandeling van baie erstige pneumonie het nie 
dieselfde wenslike effek gehad nie. In neonate (jonger as 2 maande) was daar ook geen verlaging 
in die sterftesyfer nie.  
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Laastens het ons die redes vir die swak uitkomste ondersoek in ‘n substudie en veral klem gelê op 
bydraende siektes en kliniesesorg tekorte geassosieer met pneumonie sterftes. Die studie het ‘n 
aantal faktore geïdentifiseer wat bygedra het tot die sterftesyfer in kinders met baie ernstige 
pneumonie en in neonate. Die geïdentifiseerde bydraende faktore het malaria, wanvoeding, erge 
anemie en MIV-infeksie ingesluit. Voorkomende maatreëls moet vir die geïdentifiseerde faktore 
ingestel word.  Aanpassings in die pneumonie protokolle is voorgestel.  
 
Ten slotte word aanbevelings gemaak om die geïdentifiseerde redes vir swak uitkomste aan te 
spreek en verdere navorsingidees word aanbeveel.  
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Chapter 1. 
 
Introduction 
The millennium development goal four (MDG4) aimed to reduce childhood mortality by two-thirds 
by 2015 from levels in 1990. While substantial progress has been achieved, targets will not be 
reached in many high-mortality countries. By 2000, the gap in childhood mortality between 
industrialised and sub-Saharan African countries had increased from 20-fold in 1990 to 29-fold with 
the childhood under-five mortality rates in sub-Saharan Africa averaging 175 deaths per 1000 live 
births compared to six deaths per thousand live births in industrialised countries.[1] The mortality 
reduction targets were met in only 5 of 55 countries that had an under-five year mortality rate of 
100 or more in 1990.[1] 
 
At the beginning of the study, on which this dissertation is based, the global estimate in 2000 for 
child deaths was 10.8 million - 41% of these occurred in sub-Saharan Africa and 34% is Southern 
Asia.[2] The leading causes of death with uncertainty bounds were: diarrhoea 22% (14-30%), 
pneumonia 21% (14-24%), malaria 9% (6-13%), measles 1% (1-9%), AIDS 3 %, neonatal causes 
33% (29-36%) and 9% other causes.[2] In 2013 pneumonia remained the greatest single cause of 
mortality in children less than five years of age throughout the world despite the decrease in overall 
mortality rate..[3,4,5] Bhutta et al. reported that of the 6.9 million deaths in children younger than 
five years in 2011, pneumonia remained the number one cause of death (18.8%) in children one to 
59 months. [5]    
 
Epidemiology 
 
Morbidity  
Developing countries have the highest number of episodes of pneumonia estimated at over 150 
million cases (95%) worldwide annually with 7% to 13% requiring hospitalization.[4] The average 
number of episodes per child per year is 0.29 worldwide, and in sub-Saharan Africa and South 
Asia is 0.30 and 0.36 respectively.[6] Rudan et al. reported that there was an increase in the 
proportion of severe episodes requiring hospitalisation in the lower and middle-income countries.[6] 
In a recent meta-analysis of 62 studies from developing countries the pneumonia incidence was 
highest in neonates aged <28 days (68•6 episodes per 1000 per year, 95% CI 47•8–98•4); and 
infants aged 0–11 months (51•8 episodes per 1000 per year, 44•8–59•8).[7] There were 
approximately 20 episodes per thousand children per year requiring admission for severe 
pneumonia in children aged 0–59 months.[7] The high incidence of acute respiratory infections is a 
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 2 
considerable burden on health services globally and a major cause of hospital referral and 
admission in this age group.[7] 
 
Mortality 
Nair et al. [7] estimated that in 2010 there were 11·9 million episodes of severe and 3·0 million 
episodes of very severe pneumonia in young children worldwide that required hospitalization with 
an estimated 265 000 (95% CI 160 000–450 000) in-hospital deaths, of which 99% of which 
occurred in developing countries.  Afghanistan, Democratic Republic of the Congo, India, Nigeria 
and Pakistan together have the highest proportion (52%) of all pneumonia deaths.[8] Many 
published studies have used modeling to estimate pneumonia rates and deaths for countries in 
sub-Saharan Africa where it is estimated that approximately 50% of all childhood deaths occur but 
there is very little information available based on reliable sources to confirm this.[9,10,11,12] 
According to Black et al. [8] it is these high-burden/ low-resource countries that are the ones most 
in need of information that will allow them to target specific diseases and health-care services. 
 
Of the 7•6 million deaths in children younger than five years in 2010 pneumonia remained the 
leading cause with an estimated 1.396 million deaths, 18•3% of total deaths (uncertainty range 
(UR) 1•189–1•642 million).[5] This included 4% of neonatal pneumonia deaths.  Sepsis and 
meningitis are estimated to be responsible for a further 0.393 million (5.2%) neonatal deaths. In the 
1-59 months age group diarrhoea was second and malaria third, 10•5% and 7.7% respectively of 
total deaths.  AIDS deaths were an estimated 0•159 million (2%). The burden of mortality in 
children younger than five years varied widely across World Health Organization (WHO) regions in 
2010, with the largest number of deaths seen in Africa (3•6 million) and South-East Asia (2•1 
million).  The proportion of deaths from pneumonia is dependent on the prevalence of malaria and 
Human Immunodeficiency Virus (HIV) which varies widely between regions, but even in regions 
where malaria and AIDS deaths are common pneumonia still accounts for up to 17% of deaths.[13] 
See Table 1 for regional causes of childhood deaths in 2010 due to infectious diseases. 
 
Standard Case Management Strategy 
 
Despite the heavy burden of pneumonia on child morbidity and mortality, pneumonia has been 
neglected within the area of public health for many decades in developing countries. In the early 
1980's childhood pneumonia was recognised as a major problem that needed to be addressed at a 
global level.[14] There were two schools of thought at this time as how best  
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Table1.1. Regional causes of childhood deaths in 20101  
Region Deaths/ 
millions 
Child 1 – 59 months 
% of total deaths in region* 
Neonate 0-27 days 
% of total deaths in region* 
 N=7.622 Pneumonia Diarrhoea Malaria Meningitis AIDS Pneumonia Sepsis or 
meningitis 
Africa 3.552 14 11 15** 3 4*** 3 4 
SE Asia 2.096 15 10 1 2  7 7 
Eastern 
Mediterranean 
1.062 15 11 1 3  4 5 
Western 
Pacific 
0.467 14 4  2  2 3 
Americas 0.284 8 4  1 1 2 5 
Europe 0.161 9 4  1 1 3 4 
*Causes responsible for less than 1% of deaths are not shown. 
** 95·7% of global child deaths due to malaria 
*** 89·5% of global child deaths due to AIDS 
 
to address the issue. Scientists, especially epidemiologists and microbiologists supported the idea 
that the causative agents and risk factors should be identified before any intervention strategies 
were undertaken in the control of acute respiratory infections in children in developing countries. 
This school of thought is represented today in the Pneumonia Etiology Research for Child Health 
(PERCH) project whose aim is to provide data that reflect the epidemiologic situation in developing 
countries in 2015 and address differences in host, environmental, and/or geographic factors that 
might determine pneumonia aetiology relevant to pneumonia management in the 21st century.[15] 
 
The other school of thought included experts, mainly paediatricians and community health 
specialists, who proposed that there was sufficient evidence available to define control strategies 
and that these could be implemented immediately.[16] During the 1980's, the WHO and United 
Nations International Children's Emergency Fund (UNICEF) main objective was to introduce an 
Acute Respiratory Infection (ARI) Programme based on standard case management (SCM) as it’s 
central strategy to reduce mortality from pneumonia.[17] 
                                               
1 Adapted from Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and 
national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. 
Lancet. 2012;379:2151-61. 
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Case management defined [18] 
Correct case management is the cornerstone of Programmes for the control of acute 
respiratory infections. Case management involves: 
   1  Early recognition of pneumonia by 
health workers using signs of fast breathing 
and chest in-drawing. 
 
   2  Prompt referral to hospital for 
injectable antibiotic treatment and other 
intensive care, for severe and very severe 
cases. 
   3  Antibiotic treatment at home with 
recommended drugs, for cases of 
pneumonia which are not severe. 
 
   4  Supportive home care for the vast 
majority of acute respiratory infections that 
do not require antibiotics. 
 
Scientific basis for standard case management 
The ideal approach to the diagnosis of pneumonia and other lung diseases would be to identify the 
causative micro-organism(s) in each individual case so that appropriate treatment could be 
prescribed.  However, the limitations of diagnostics at the time, which presently still exists,  did not 
allow for such an approach.[19]   A confirmed bacterial cause of pneumonia in children can usually 
only be established by culture of lung (or pleural fluid) aspiration or blood.[20]  Blood cultures are 
positive in only a small portion of children even with severe pneumonia, and obtaining specimens from 
lung or pleural aspiration is usually not feasible in most routine situations as well as exposing the child 
to a risk of a serious complication.[20]  Auscultation and radiological findings are unreliable means of 
determining the aetiology of pneumonia in children. Clinical information such as leucocyte count and 
the level or evolution of fever are imprecise in defining the bacterial or viral aetiology of 
pneumonia.[20] Due to the limitations of diagnostics a standard management approach for 
pneumonia in children including empirical use of antibiotics was adopted based on simple clinical 
signs.[20] 
 
Faced with children presenting with cough or difficult breathing, especially in hospitals with 
diagnostic limitations, health workers must be able to distinguish those children that have 
pneumonia rather than the more common upper respiratory tract infection as well as determine 
severity of pneumonia in order to promptly treat potentially fatal cases.  Standard case 
management includes classification of severity of pneumonia in children based on a limited number 
of clinical signs. It ensures that those requiring antibiotics receive the appropriate antibiotic at the 
appropriate dose.  The use of empirical antibiotic therapy for pneumonia is a commonly accepted 
practice worldwide. In low-income countries, and especially in those with high infant mortality rates 
(IMR), as many as half of pneumonia cases in children attending health services may be of 
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bacterial origin and bacterial pneumonia is more likely to be fatal than pneumonia due to common 
respiratory viruses.[21] Simple clinical signs, without a chest x-ray or laboratory investigations, can 
diagnose almost all of these cases of pneumonia.  
 
Diagnosis 
In the early 1980s research was undertaken to identify simple clinical criteria for detecting 
pneumonia.[22] These studies found that the presence of fast breathing and lower chest wall in-
drawing in any child under five years of age presenting with cough or difficult breathing was highly 
predictive of pneumonia and the need for antibiotic treatment and hospitalization.  
An increase in respiratory rate (rapid breathing) is one of the physiological responses to hypoxia 
and stiff lungs. However, it can also occur if a child is frightened, upset or feeding, so it is essential 
that the child be calm when the respiratory rate is measured. Since the normal respiratory rate in a 
young infant (less than 2 months) is higher than in older infants and children, a higher threshold for 
case detection is used in this age group. Furthermore, the greater variability in respiratory rate in 
this age group requires that the finding of an elevated rate be checked by a second count after an 
interval to ensure that the child is calm. Clinical studies carried out in the Gambia, [23] India, [24] 
and the Philippines [25] validated the use of clinical signs and refined the age-specific criteria used 
to diagnose pneumonia. The recommended upper limits of respiratory rates were defined as: 60 
per minute for infants below 2 months; 50 per minute for infants aged 2—12 months; 40 per 
minute for children aged 12—59 months.  
 
Stiff lungs (decreased lung compliance) resulting from severe pneumonia cause chest in-drawing 
during inspiration. Studies showed that children who present with lower chest in-drawing are more 
likely to have severe pneumonia than children without this sign.[21,22]  As the respiratory rate can 
fall when pneumonia becomes more severe or the child is exhausted, the use of both signs results 
in detection of a higher proportion of severe pneumonia cases. Several clinical studies that have 
compared clinical signs with a chest radiograph have shown that fast breathing and chest in-
drawing can very efficiently identify cases of pneumonia in young children with cough or difficult 
breathing who are not wheezing.[26] 
 
The majority of studies [22-26] found that the presence of fast breathing and lower chest wall in-
drawing in any child under five years of age presenting with cough or difficult breathing was highly 
predictive of pneumonia with a sensitivity > 80% and specificity > 90% for both. 
 
The highest case-fatality rates occur in children who are either cyanosed and/or not able to drink – 
features that are used for the classification of very severe pneumonia. The presence of either of 
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these signs in children with cough or difficult breathing indicates an urgent need for admission and 
intensive therapy including oxygen and broad-spectrum parenteral antibiotics.[27,28] These 
findings provided the rationale for pneumonia case detection using clinical signs and symptoms 
without the need for auscultation or radiography: this forms the basis for empirical treatment of 
childhood pneumonia.[29] 
 
Standard case management of community acquired pneumonia (CAP) in hospitalized children in 
developing countries was based on: 1) Streptococcus pneumoniae and Haemophilus influenzae 
being the most common causes of bacterial pneumonia, [30] 2) simple clinical signs having high 
sensitivity and specificity (in high mortality settings) for the diagnosis of pneumonia without the 
need for auscultation, radiology or laboratory investigations; [22] 3) effective, safe and cheap 
antibiotics being available to treat pneumonia both as an out- or inpatient.[31] These facts formed 
the basis for the empirical treatment of childhood pneumonia and became “the corner-stone of the 
current [WHO] case management strategy for the control of ARIs in children.”[32] 
 
Treatment 
 
Aetiology and antimicrobials 
During the 1970s and 1980s studies carried out in developing countries on lung aspirates and 
blood cultures from hospitalized children with untreated community-acquired pneumonia showed 
that bacteria were present in more than 50% of cases and that Streptococcus pneumoniae and 
Haemophilus influenzae were the predominant bacteria, accounting for two-thirds of all bacterial 
isolates.[31,33-37] The BOSTID study findings published in 1990 of children admitted for 
pneumonia in sites in 5 countries found that a higher proportion was due to viral as opposed to 
bacteria infections with range 14% to 64%.  Bacterial infection was found in 4.5% to 40% with 
Streptococcus pneumoniae and Haemophilus influenzae being the predominant bacteria.[38] 
 
In 1990 the WHO published recommendations, based on these earlier findings for the standard 
antibiotic treatment for pneumonia using antimicrobials effective against these two bacteria.[39] 
The antibiotics of choice, for children two to 59 months, were amoxicillin or cotrimoxazole for non-
severe pneumonia, benzylpenicillin for severe pneumonia and chloramphenicol for very severe 
pneumonia.  The recommended treatment for infants less than two months was parenteral 
gentamicin and benzyl penicillin.    
 
These recommendations were made prior to the HIV era and have since been shown to be not as 
effective in HIV positive children with pneumonia [40-42] and therefore the WHO introduced new 
recommendations in 2005.[43] For children with severe/very severe pneumonia who are HIV 
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positive or in whom HIV is suspected ampicillin plus gentamicin for 10 days is recommended.  If 
the child does not improve within 48 hours then the recommendation is to change to ceftriaxone 
(80 mg/kg IV once daily over 30 minutes) if available. If not available then gentamicin plus 
cloxacillin is recommended.[43] Also recommended is high-dose cotrimoxazole (eight mg/kg of 
trimethoprim and 40 mg/kg of sulfamethoxazole IV every eight hours or orally three times a day) for 
three weeks.[43]   Antibiotic treatment for severe pneumonia remained the same whereas that 
recommended for very severe pneumonia changed to ampicillin and gentamicin as  well if 
available.[43] 
 
Blood culture studies from tropical Africa have found that non-typhoidal Salmonella is a common 
isolate from children with a clinical diagnosis of pneumonia.[44-47] Other common causes are 
respiratory viruses, [48,49] pertussis and measles.[50] Pneumonia is a frequent and major 
complication of measles - the most frequent bacteria reported as cause of secondary infection are 
Streptococcus pneumoniae and Staphylococcus S aureus.[51] Herpes virus and adenovirus can 
cause measles-associated pneumonia.[51] Recommendations for treatment of measles–
pneumonia is the same as above for very severe pneumonia.  
 
With the introduction of conjugate vaccines that protect against Haemophilus influenzae type b 
(Hib) and common serotypes of Streptococcus pneumoniae over the last decade, there has been an 
impact on the incidence of bacterial pneumonia and meningitis.[52-54] The Hib vaccine, which is now 
routine in many countries has been shown to be highly efficacious  – although less effective in HIV-
infected children.[5 The pneumococcal conjugate vaccine (PCV) is also very effective [56-58] and 
since 2010 has been increasingly implemented in high burden settings in Africa. Even the recognised 
challenge of needing to cover a broader range of serotypes in the African region compared to the 
United States of America (USA) is being addressed with implementation of PCV 13 replacing the 
original PCV 7 valent vaccine.[59,60] The Global Alliance for Vaccines and Immunisation (GAVI) in 
their 2014 annual report for pneumococcal Advance Market Commitment  (AMC) for vaccines stated 
that by the end of 2013 of the 73 AMC countries eligible and approved for support to introduce 
pneumococcal vaccines 40 had done so, eight had introduced PCV10, while 32 countries are using 
PCV13.[61] 
 
A 2008 Cochrane review of 11 publications from six randomised clinical trials  (RCTs) conducted in 
Africa, US, Philippines and Finland comparing PCV with placebo in children under two with invasive 
pneumococcal disease (IPD) found that PCV is effective in preventing IPD.[62]   Efficacy all 
serotypes-IPD was 58% (95% CI 29% to 75%, P = 0.001). In X-ray defined pneumonia it was 27% 
(95% CI 15% to 36%, P < 0.0001) and in clinical defined pneumonia 6% (95% CI 2% to 9%, P = 
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0.0006). All-cause mortality was 11% (95% CI -1% to 21%, P = 0.08).  Similar results were found in 
HIV-1 positive children.[62] 
 
Although both Hib and PCV are safe and effective in the prevention of radiologically confirmed 
pneumonia in children, they only target selected pneumonia pathogens and are less than 100% 
effective. Therefore, they must be accompanied by both curative care and other preventative 
strategies.[63] 
 
While both Hib and PCV have a lower efficacy in HIV-infected children [43,46], they do provide some 
coverage directly and indirectly through herd immunity and reduced carriage. Given the huge 
increased risk for bacterial pneumonia in the HIV-infected, even a reduced efficacy results in 
prevention of a large numbers of cases. Further, the risk of HIV-related pneumonia is falling in the 
region due to a declining risk of new HIV infections in babies, as well as protective effects of 
cotrimoxazole preventive therapy (CPT) and antiretroviral therapy (ART).    
 
Co-morbidities influencing aetiology in high burden countries 
 
The aetiology of pneumonia in high-risk immunosuppressed children is different from that of 
immuno-competent children.  Streptococcus pneumoniae and Haemophilus influenzae remain the 
primary cause of infection but there is a broader spectrum of pathogens found in the 
immunosuppressed child with pneumonia therefore antibiotic treatment recommendations need to 
be tailored to these high-risk groups.[64-67]      
 
 
HIV 
An increase in paediatric HIV infection has had a substantial impact on childhood morbidity and 
mortality worldwide. HIV infection in children living in HIV endemic countries is due largely to mother-
to-child transmission.  Estimated transmission rates for developed countries are less than two per cent 
whereas in developing countries the range is 25 to 48% with interventions available to only 5%-10% 
of women.[68] It is estimated that there are currently more than 2.3 million children living with HIV 
worldwide of which 2 million (90%) live in sub-Saharan Africa.[69]  These children become 
symptomatic in the first few years of life with >80% developing a respiratory disease at some point 
during the course of their illness.[70] A study in South Africa showed that the implementation of 
Prevention of Mother to Child Transmission (PMTCT) intervention of a single dose of Nevirapine 
(NVP) given to the mother at the onset of labour and to the baby within 72 hours of birth reduced 
MTCT of HIV significantly with lower rate of transmission at six weeks (8.7%) and 14 weeks 
(8.9%).[71] Another study from South Africa showed that the early HIV diagnosis and early 
Stellenbosch University  https://scholar.sun.ac.za
   
 
 9 
intervention with antiretroviral therapy reduced early infant mortality by 76% and HIV progression 
by 75%.[72] 
 
In southern African countries it is estimated that between 35 to 65% of children admitted with severe 
pneumonia are co-infected with HIV and have a higher case fatality rate (CFR) (34%) than children 
with pneumonia who are HIV negative (9%).[73]   Autopsy and clinical studies from the high HIV 
prevalent (>1% prevalence) setting have indicated that acute pneumonia in HIV-infected infants 
and children is caused by a wider range of pathogens than in those who are not HIV-
infected.[64,74] In addition to bacteria, respiratory viruses and tuberculosis (TB), pneumonia 
associated with Pneumocystis jirovecii (PcP) and cytomegalovirus (CMV) are commonly reported. 
[41,46,65,75-79] 
 
Most episodes of pneumonia in HIV-positive children have the same aetiology as in HIV-negative 
children and respond to the same treatment but there is a higher rate of failure due to a wider range 
of pathogens.[40,41,65]  If the pneumonia does not respond to standard treatment and there is 
hypoxia that responds poorly to oxygen therapy then Pneumocystis jirovecii pneumonia should be 
considered.[46] Those most at risk are infants less than six months of age living in HIV-endemic 
regions.[80]  See section on Aetiology and Antimicrobials for WHO recommendation for treatment of 
PcP. 
 
Tuberculosis 
Chintu et al. reported that Mycobacterium tuberculosis was the third most common autopsy finding 
(18.8%) in Zambian children dying from pneumonia irrespective of their HIV status.[77] Prospective 
clinical studies of South African children hospitalized with severe pneumonia confirmed TB as the 
cause in 7-8% of admissions. [65,78]  A more recent study of children admitted with severe/very 
severe pneumonia (WHO-defined) found that 15% had culture-proven TB.[41] A child with 
persistent fever and signs of pneumonia and those not responding to antibiotics, should be 
evaluated for tuberculosis such as by enquiring about recent close contact with a TB case.   
 
Malnourished children 
Severely malnourished children are very immunosuppressed and have a higher incidence of 
pneumonia and related mortality.  They have a broad spectrum of causative agents that includes 
bacterial infection with S pneumoniae, H influenzae, Escherichia Coli, Klebsiella pneumoniae, 
Staphylococcus aureus, non-typhoidal Salmonella species, Pseudomonas aeruginosa and 
Mycobacterium tuberculosis. Viral pathogens include RSV, Influenza, Measles, Varicella and CMV, 
as well as fungal infections caused by Pneumocystis jirovecii and Candida albicans.[81] The 
treatment regimen recommended for these children includes cotrimoxazole prophylaxis on 
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admission if not acutely ill or a broad-spectrum injectable antibiotic such as chloramphenical or 
ampicillin plus gentamicin if clinical pneumonia or sepsis is diagnosed.[43] 
 
Young infants 
The WHO’s multi-centred Young Infant Study (less than 2 months of age) on pneumonia, sepsis 
and meningitis found that the most common isolates from blood were Staphylococcus aureus 
(20.4%), Streptococcus pneumoniae (19.8%) and Streptococcus pyogenes (17.4%).[82]   The 
gram-negative isolates were less frequent, Escherichia coli (11.4%), Salmonella species (10.2%), 
Haemophilus influenzae (4.2%) and Klebsiella pneumoniae (3.0%).  Streptococcus pyogenes, 
Staphylococcus aureus and Escherichia coli were the most common organisms isolated in the first 
month of life and Streptococcus pneumoniae in both the second and third months of life.  Group B 
Streptococcus, the most common pathogen found in neonates in developed countries was only 
found in 1.2% of all bacterial isolates. A recent study of young infants also found that 
Staphylococcus aureus was the most common organism isolated (43.4%) followed by Gram-
negative bacilli (46.9%) with the most common organisms being Escherichia coli and Klebsiella 
pneumonia.[83] The study also reported high levels of resistance to second and third generation 
cephalosporins and gentamicin.[83]  In contrast, studies from Malawi and Kenya have found Group 
B Streptococcus to be the commonest isolate: 136 or 17% of 784 isolates from Malawian 
neonates.[84-86] 
 
The recommended regimen for severe pneumonia or very severe pneumonia/disease in the infant 
less than two months is a combination of injectable ampicillin or benzylpenicillin plus gentamicin 
which covers the majority of these pathogens.  If the response to treatment is poor, intramuscular 
or intravenous cefotaxime plus intramuscular ampicillin is recommended.[43]  
 
Recent revisions to antibiotic recommendations 
 
In 2005, the WHO published recommendations based on new research.[87]  For the treatment of 
non-severe pneumonia in children 2-59 months of age, oral amoxicillin or oral cotrimoxazole in low 
HIV-prevalent countries is recommended for a shorter period of three instead of five days. For 
severe pneumonia, in this age group the recommendation for hospitalized children remains 
unchanged but where referral and injectable antibiotic is not possible then the recommendation is 
oral amoxicillin in 45 mg/kg/dose twice daily for five days. For very severe pneumonia in children 2-
59 months of age injectable ampicillin and gentamicin is now being recommended over that of 
injectable chloramphenicol.[88] 
 
Factors influencing outcome of pneumonia: 
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Several important environmental risk factors and endogenous (host) modifiers have been identified 
that influence the outcome of pneumonia in children. 
 
Age 
Infection, particularly pneumonia, sepsis and meningitis are major contributors to high mortality rates 
in young infants less than two months of age in developing countries with the majority of pneumonia-
related deaths occurring in infants less than 12 months of age.[86,89]  A meta-analysis of studies 
carried out in 1992 on age-related fatality rate due to pneumonia showed that 20.8% of deaths 
occurred before one month of age, 57.8% between 1-11 months, and 21.5% at 12-59 months – no 
confidence interval (CI) reported.[90]   More recent studies on age-related fatality rate due to 
pneumonia reported the following: McNally et al. found in-hospital mortality was highest in age <12 
months OR=3.37 (95%CI 1.41-10.25).[40]   Naheed et al. also reported in-hospital mortality was 
highest in age <12 months OR=2.0 (95%CI 1.3-3.2).[91] Sigauque et al. reported deaths by age 
groups: 12-23 months 28% OR=1, 2-11 months 60% OR=1.44 (95%CI 0.63-3.31) and <2 12% 
OR=1.48 (95%CI 0.86-2.54) – which again showed that children <12 months were at a higher risk 
of dying from pneumonia.[92] 
 
Malnutrition 
Underweight children are at a higher risk of dying from infectious diseases with approximately 50% 
of all deaths being attributed to this factor.[93,94] There is a five-fold risk for pneumonia in children 
that are malnourished.[95]  Malnutrition is estimated to contribute to 35% of child deaths globally as 
a common co-morbidity in child deaths reported as due to diarrhoea, pneumonia, measles and 
malaria.[95] The fraction of disease attributable to being underweight was 61% for diarrhea, 57% for 
malaria and 53% for pneumonia.[95] Caulfield et al. reported that the risk of dying from pneumonia 
was highest in those with >three SDs malnutrition RR=8.09 (95%CI 4.36-15.01) and a RR=4.03 
(95%CI 2.67-6.08) with -2 to -3 SDs.[96]   Nantanda et al. reported that children with severe 
malnutrition and pneumonia also had a higher risk of dying OR=16.5 (95%CI 4.2-65.5).[97]  
Naheed et al found mortality was higher in malnourished children admitted with pneumonia 
OR=4.6 (95%CI 2.9-7.4).[91] Chisti et al. reported similar findings in his review of malnourished 
compared to well-nourished children with moderate malnutrition and pneumonia RR= 4.03 (95%CI 
2.67-6.08) and severe malnutrition and pneumonia RR=8.09 (95%CI 4.36-15.01).[81] 
 
Micronutrient deficiency  
Findings from a pooled analysis of randomized controlled trials of zinc supplement for children in 
developing countries showed that the pneumonia incidence was significantly reduced in those 
children receiving zinc (OR 0.59, 95% CI 0.41 - 0.83). [98]   Aggarwal et. al.   in a meta-analysis 
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found that there was a significant reduction in the incidence of pneumonia in children receiving zinc 
as opposed to a placebo (RR 0.80, 95% CI 0.70 - 0.92).[99] A Ugandan study found that zinc 
reduced case-fatality in HIV-infected children with severe pneumonia.[100] A systematic review 
carried out by The Lancet Diarrhoea and Pneumonia Interventions Study Group reported that zinc 
supplementation resulted in a 28% reduction in pneumonia-specific mortality (RR 0·72, 95% CI 
0·23–2·09), a 50% reduction in hospital admissions for pneumonia (0·50, 0·18–1·39), and an 
observed 23% reduction in pneumonia prevalence (0·77, 0·47–1·25).[101]  Another study on the 
number of pneumonia interventions reported that zinc supplement reduced the incidence of 
pneumonia by 14–25% (90% CI: 8–30).[102] Bryce, et al. in a study of the 20 countries with the 
highest rates of under nutrition, reported that only four countries were implementing zinc 
supplementation, two implementing nation-wide and two implementing it in selected districts 
only.[103] 
 
Supplementation of vitamin A has been shown to have no direct effect on pneumonia incidence or 
mortality but there are indirect benefits in that the risk of mortality and morbidity from measles, 
diarrhoea, HIV and malaria decreases.[104] Bryce, et al in 2006 found that 56 out of 60 priority 
countries reviewed had a national vitamin A supplementation programme - but that only 46% had 
coverage of >70% and that 12.5% had rates of  <40% with 26.8% of countries having no data.[105] 
 
Low birth weight 
Low birth weight is associated with reduced lung function [106] and infants whose birth weight is 
below 2.5 kilograms are at a higher risk (1.69 p<0.005) of admission for pneumonia [107] and 50% 
more likely to die from pneumonia during the first year of life than infants with normal weight at 
birth.[108] 
 
Breast feeding: 
Sub-optimal breast-feeding increases the risk of developing pneumonia OR 3.1 (1.91-5.01). [108] 
Infants not being exclusively breastfed had a 17 times increase of requiring hospitalization for 
pneumonia (95% CI 7.7 - 36.0), and the younger the age the higher the relative risk especially for 
infants below 3 months of age: RR 61 (19.0 - 195.5) subsequently decreasing to RR 10 (2.8 to 36. 
2).[109] In a population with a high prevalence of HIV infection there is a major risk of transmission of 
HIV-1 from a positive mother to her infant through breastfeeding – approximately 40% of HIV infected 
infants acquired the disease via this route.[110] However, the benefits of breast-feeding still far 
outweigh the risk of not breast feeding the young infant, especially now in the era of PMTCT and 
maternal ART programmes only a small proportion of HIV-exposed infants will become infected by 
this route. The introduction of PMTCT intervention  that start HIV+ pregnant women on life-long 
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ARTs regardless of CD4 cell count has shown a significant reduction of  the risk of transmission 
through breast milk (0.5% - 0.7%).[80,111]  
 
HIV 
There are a number of strategies that could potentially reduce the burden of HIV-related lung 
disease.[112]   These include reducing antenatal HIV prevalence and prevention of mother-to-child 
HIV transmission.  According to the Joint United Nations Programme on HIV/ Acquired Immune 
Deficiency Syndrome (UNAID) 2013 report the expansion of programmes for PMTCT and the use of 
more effective ART regimens helped prevent more than 800 000 children from becoming newly 
infected between 2005 and the end of 2012.[113] 
 
A study by Chintu et al. on cotrimoxazole preventive therapy (CPT) reported pneumonia was more 
frequent in the placebo group as opposed to the treatment group as was the mortality rate  - 35 out 
of 112 deaths in the placebo group with 13 of 74 deaths in the treatment group  (p=0·04).[114]  The 
WHO recommends that CPT be provided for all HIV-infected children as a randomized-controlled 
trial reported improved survival with a significant decrease in death and hospitalization by 43% and 
23% respectively.[115] CPT should also be provided to all HIV-exposed and infected infants from 
birth as it prevents PcP which is common in this age group.[116] 
 
The most significant intervention is the early introduction of ARTs which has been demonstrated, in 
regions where this has been implemented, to decrease the incidence, [117] overall and pneumonia 
specific mortality rates.[72] Violari et al. compared early versus deferred antiretroviral therapy in 
HIV-infected infants 6 to 12 weeks of age with a CD4 lymphocyte percentage of 25% or more.[72]  
They reported that  early HIV diagnosis and early antiretroviral therapy reduced HIV progression by 
75% - 26% in the deferred-therapy group versus six per cent of infants in the early-therapy group - 
hazard ratio for disease progression, (0.25; 95% CI, 0.15 to 0.41; P<0.001).  In pneumonia 
adverse events, grade three or four, in infants in the early-therapy group there was 25 cases 
(12.2%) versus 25 (26.5%) in the deferred-therapy group – in pneumonia grade one or two there 
were 66 (32.1%) and 56 (59.4%) cases respectively. Early infant mortality was reduced by 76% - 
overall death rate per 100 person-years in the deferred-therapy group was 21.2% (95% CI 13.0–
32.7) and in infants in the early-therapy group 4.9% (95% CI 2.3–9.0) - hazard ratio for death,(0.24; 
95% CI, 0.11 to 0.51; P<0.001).  Of the four in-hospital pneumonia deaths all occurred in the 
deferred-therapy group.[72]  ART is still not readily available for all eligible HIV-infected children 
with only 29%-36% receiving treatment.[118] 
 
Indoor Air Pollution 
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Approximately 50% of all people globally, most living in low-income countries, rely on solid fuel for 
cooking, lighting and heating.[119,120,121]  More than 75% of the population in India, China and 
nearby countries, and 50–75% of people in parts of South America and Africa continue to cook 
with solid fuels such as dung, wood, agricultural residues or coal.[122] Cooking indoors in a poorly 
ventilated room leads to high levels of indoor air pollution due to biomass particles and smoke.   
 
There is an increased incidence in pneumonia in relation to the amount of time-spent daily exposed to 
this type of pollution. The risk of pneumonia in young children is increased by exposure to 
unprocessed solid fuels by a factor of 1.8 [123] with 56% of global deaths attributed to indoor smoke 
in children less than five years of age [124] - this translates into deaths due to pneumonia among 
children under five years of age as nearly 800 000; 358 000 in Africa, and 288 000 in South-East 
Asia.[125]  
 
Many studies have been carried out on the effects of indoor air pollution (IAP) on child lung health but 
to date only one intervention study has examined the impact of introducing an alternative way of 
cooking/heating in relation to reduction in childhood pneumonia.[126] Additional research is required 
before recommendations, as to what intervention is the most cost-effective or efficient, can be 
made.  
 
Environmental tobacco smoke 
Children exposed to second-hand tobacco smoke have an increased incidence of pneumonia, 
which is associated with the number of people who smoke within the household. [127,128] A USA 
meta-analysis on respiratory effects in children exposed to environmental tobacco smoke (ETS) 
concluded that there was sufficient evidence to infer a causal relationship between ETS exposure 
and an increased risk of lower respiratory tract infections (LRTIs), such as bronchitis and 
pneumonia and an increased severity of asthma.  The risk increases when the mother 
smokes.[129]   
 
Lack of access to oxygen 
In children with severe/very severe pneumonia, hypoxaemia is common and associated with 
mortality, increasing the risk of dying five-fold.[130,131] Hospitals have very limited access to 
oxygen throughout the developing world, [132] and when oxygen is available the equipment 
required to deliver it is often lacking.[133,134] Pulse oximetry is also not widely available, making 
staff dependent on clinical signs to diagnose hypoxaemia.  There are published technical 
guidelines for oxygen therapy in the management of childhood pneumonia in low-income countries, 
covering the indications for use, sources and equipment for the administration of oxygen.[135] In 
the absence of pulse oximetry these guidelines recommend a combination of clinical signs to 
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diagnose hypoxaemia. An implementation study in five district hospitals in Papua New Guinea 
showed that the introduction of oximetry, oxygen therapy and training reduced pneumonia-related 
mortality in children by one-third. [136] 
 
Inadequate immunization coverage  
Immunization dramatically reduces the incidence of common childhood diseases such as pertussis, 
diphtheria, tetanus, poliomyelitis and measles.  Vaccination has had an important effect on measles 
incidence and mortality, and in the past measles was a major cause of pneumonia-related deaths.  
Global measles vaccine coverage is >75% but several regions, particularly South Asia and sub-
Saharan Africa have a much lower rate.[137]  Measles can cause deaths due to pneumonia either 
directly or more commonly indirectly as it is complicated by secondary bacterial pneumonia such as 
due to Staphyloccocus.  Bryce et al.  found only 10 out of 60 priority countries were on track for 
achieving 90% coverage of DPT3 and measles vaccines by 2015.[105] 
 
As noted above, the implementation of the Hib vaccine and the widening coverage of the PCV is 
preventing bacterial pneumonia and deaths in many high-burden settings.  Bhutta et al. reported that 
measles vaccine was 85% (95% CI 83–87) effective in prevention of measles in infants <12 
months which affects the risk of subsequent complications, including 
secondary bacterial infections; Hib vaccines reduction in severe pneumonia was six per cent (RR 
0·94, 95% CI 0·89–0·99) with a seven per cent (0·93, 0·81–1·07) reduction in pneumonia mortality.   
Pneumococcal vaccines resulted in an 11% (0·89, 0·81–0·98) reduction in severe pneumonia with 
an 18% (0·82, 0·44–1·52) non-significant reduction in pneumonia mortality.[101] 
  
Lack of access to quality health care and trained staff 
Weak health systems that are chronically underfunded result in many health workers being poorly 
paid, or in some cases not paid at all, leading to high attrition rates (8% to 60%) with many migrating. 
[138]  Bryce et al.  found that <10% of health workers providing care to children had been trained in 
SCM of childhood pneumonia and that the attrition rate of trained staff was as high as 40% within 2 
years of their receiving training.[139]  
 
In many developing countries, especially in sub-Saharan Africa, this lack of human resources 
necessary to deliver the most basic health care is a major problem.  Fourteen percent of the world’s 
population lives in Africa, they bear a quarter of the global burden of disease but only have 1.3% of 
global health workers.[140]  The HIV/Acquired Immunodeficiency Syndrome (AIDS) epidemic, 
especially in sub-Saharan Africa, has put a further strain on already over-burdened, under-funded and 
under-staffed health systems and is further reducing the workforce from AIDS related death.  
According to the 2002 UNAIDs Report the rising incidence of HIV-positive health workers led to more 
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absenteeism, reduced productivity and higher training and recruitment costs with some countries 
experiencing five- to six-fold increases in health-worker illness and death rates.[141]  
 
Malawi experienced a six-fold increase in mortality of health workers from AIDS-related diseases 
between 1985 (0.5%) and 1997 (3.0%) - other sub-Saharan African countries reported similar trends – 
especially South Africa.[138] In  2007 Malawi health service vacancy levels remained static at 46% 
due to a high attrition rate and deaths which alone represented 50% of all trained staff losses.[142] 
The human resource (HR) capacity of the MOH to implement the Sector Wide Approach (SWAp) and 
to deliver the Essential Heath Package (EHP) is still limited even with an increase of 53% of health 
personnel between 2004 to 2010 there are still significant vacancies for priority Health Care Workers 
mainly nurses, physicians, clinical officers, environmental health officers, laboratory and pharmacy 
technicians.[142]  According to the Malawi Health Sector Strategic Plan (HSSP) for 2011 to 2016: 
“The human resource challenges remain both acute and complex and HR 
projections show that at current output levels it will take many years to come 
anywhere near the numbers of health staff needed to provide minimum standards of 
service delivery.” [142] 
 
Poor pay, lack of motivation and the perception that they are under-valued often leads to health 
workers failing to staff health facilities, as many open private practices to replace their lack of 
government salaries.[132,134] Underfunded health systems result in many facilities having few or 
no antibiotics and supplies to treat those children accessing care.  Often health centres are lacking 
supervision, referral systems and transport.  In these circumstances mothers lose confidence in the 
health care system.[143]  A household survey carried out in 2000 in Malawi reported that 54% of 
child deaths occur in the community (at home) and that 24% of those children dying had not been 
to the hospital/had contact with a health worker for the disease that caused their deaths.[144] 
 
Standard case management of pneumonia, as well as other relatively inexpensive child survival 
interventions are readily available but global coverage is less than 50% for most of them - with 
universal coverage of these interventions it is calculated that 63% of child deaths can be 
prevented.[145] Treatment of pneumonia remains low as reported In the Countdown 2015 report 
for 2012 - of the 45 countries who had data on antibiotic treatment the median coverage was 39% 
(range 3%-88%).[146] 
 
 
 
 
Effectiveness of SCM of pneumonia at the primary level 
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A meta-analysis of nine community-based trials to evaluate case management has been 
reported.[147]  It included four studies in countries in South-East Asia, one Western-Pacific 
country, one Eastern Mediterranean country and one country in Africa. The overall reduction in 
mortality, in three age-groups (neonates, infants <1 year and children 0-4 years), was 27%, 20% 
and 24% respectively, while in the same three age groups pneumonia specific mortality reduction 
was 42%, 36% and 36% respectively. Theodoratou et al. 2010 review of the effect of case 
management with antibiotic treatment of pneumonia at the community level reported thepneumonia 
mortality rate reduction of children 0–5 years old was 35% (95% CI 18–48%).[148] 
 
The Integrated Management of Childhood Illness (IMCI) strategy includes case management of 
pneumonia, diarrhoea, malaria and measles, as well as malnutrition at the primary level of care.   By 
2002, IMCI had been introduced into most developing countries worldwide. In the 2004 report, it was 
reported that the evaluation team had great difficulty finding countries where IMCI was sufficiently 
implemented to allow any degree of assessment of “reasonable change” mainly due to weak health 
systems unable to support such a horizontal approach.[149] Two exceptions are Tanzania [150] and 
Bangladesh [151] that demonstrated significant changes in the quality of care and decrease in 
mortality following implementation of IMCI at primary level facilities. A survey carried out by Marsh et 
al. of 57 high burden countries on community case management (CCM) of pneumonia found only 
50% (27/57) reported some implementation of CCM for pneumonia, most on a small scale.  
Information was received from 33 of the 35 highest mortality countries of which only 14 reported 
implementation of CCM of pneumonia.[152] 
 
Inpatient care of children with severe pneumonia 
 
The majority of studies reviewed by Theodoratou et al. on inpatient management of pneumonia 
focused on the effect/outcome of various antibiotic regimens.[148] Very few studies have examined 
the quality of curative care at first level referral hospitals in developing countries for children with 
common, serious diseases that are referred by primary-level IMCI.  Studies that have been 
undertaken, identified similar problems leading to poor quality of care.[132,134,153]  The main 
ones being poor case management including inadequate triage and assessment, over or under 
diagnosis of severe illness, and lack of implementation of appropriate guidelines for managing 
severe illness. Other identified problems were over, under or inappropriate treatment with 
antibiotics, fluids and oxygen and lack of ongoing assessment/monitoring of the severely ill child.  
Problems identified within health systems included lack of appropriately trained health workers at 
all levels, insufficient level of staffing, poor supervision of staff, lack of quality assurance monitoring 
and insufficient supplies, drugs and equipment.[154,155] 
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The SCM intervention strategy has been shown to be efficacious.  It works, and is relatively 
affordable.  The problem is that in most low-income countries the health services are unable to 
deliver these interventions to a sufficient number of children at a level of quality and coverage that 
would result in a significant impact.[139,156,157] 
 
Study justification 
 
There are three research approaches that can be followed to reduce the incidence of and the case 
fatality from childhood pneumonia.  The first approach focuses on research into the causative 
agents and risk factors to provide data that reflect the epidemiologic situation in developing 
countries and address differences in host, environmental, and/or geographic factors that might 
determine aetiology relevant to pneumonia management in the 21st century. This approach focuses 
on the change of organisms causing pneumonia after the introduction of conjugate pneumococcal 
and Haemophilus influenzae vaccine and determining optimal treatment of children with severe 
pneumonia. These studies concentrate on what would be the optimal treatment rather than on the 
delivery of the treatment.  
 
The second approach focuses on decreasing the number of children developing pneumonia 
through specific preventive interventions – this includes research into effects of breast-feeding 
(15%-23% incidence reduction in infants), micronutrients such as zinc (14%-25% incidence 
reduction), indoor air pollution (75% incidence reduction in specific settings) and immunization 
(PCV and Hib incidence reduction 23%-35% and 22%-34% respectively). 
 
Neither of these interventions addresses the present needs of children presenting to health 
facilities with acute pneumonia.  The third approach focuses on improving the access to care and 
delivery of correct management of children presenting with pneumonia based on the proven 
effective intervention that is presently available – SCM. For children living in the developing world 
the implementation of SCM of pneumonia reduces the CFR at community level by 34%-50% and 
facility based level by 29% -45%.[102] This is an operational based research model which 
analyses the delivery of public health interventions, determines present limitations and strives to 
correct these limitations. The advantage of this approach is that access-to-services are improved, 
standardised interventions of known efficacy made available throughout a country and the effect of 
the intervention measured. 
 
Most research on facility based management of pneumonia has focused on the effect of different 
antibiotic regimens on pneumonia outcomes as opposed to research into the SCM strategy that 
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can enhance the quality, coverage, effectiveness and performance of the programme in which the 
research is being conducted. No studies have been published describing the challenges of a 
country wide introduction of SCM of pneumonia and the effect of SCM on case fatality rates. The 
research of this dissertation is designed to evaluate the existing knowledge (papers one and two) 
and to describe operational research to evaluate practice in implementation in a specific setting 
(papers three to seven). 
 
The process utilized to carry out the research was a stepwise approach with specific aims. 
 
1) To examine the published evidence of effectiveness of SCM in HIV infected children with 
severe or very severe childhood pneumonia (paper one). 
This aim is addressed in chapter two. 
 
2) To describe the utility of oxygen therapy for treatment of children with severe and very 
severe pneumonia (paper two).  
These aims are addressed in chapter three. 
 
3) Identify the challenges relating to the implementation of SCM of pneumonia in all first-
level referral hospitals throughout Malawi, a high-burden/low-resource country (paper 
three). 
This aim is addressed in chapter four. 
 
4) To evaluate the steps in the development and implementation of a national Child Lung 
Health Programme (CLHP) to deliver SCM of severe and very severe pneumonia in all 
paediatric inpatient wards in all first-level referral hospitals throughout Malawi (paper four). 
The diagnosis of pneumonia was based on SCM protocol clinical signs and symptoms only 
and was made by paramedical health workers i.e. Clinical Officers and Medical Assistants.   
To describe the process of providing uninterrupted oxygen supply in all paediatric wards in 
first level hospital throughout Malawi at District Hospitals for children with severe and very 
severe pneumonia (paper five). 
This aim is addressed in chapter five. 
 
5) To evaluate the trend in pneumonia specific case fatality rate over time following the 
implementation of a Child Lung Health Programme (CLHP) within the existing government 
health services in throughout Malawi to improve delivery of pneumonia case management 
(paper six). 
This aim is addressed in chapter six. 
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6) To investigate the influence of management and co-morbidities on pneumonia CFR in 
children less than five years admitted with severe and very severe pneumonia to district 
hospitals in Malawi (paper seven).  
This aim is addressed in chapter seven. 
 
For papers four to seven, the research outline was as follows:  
 
Research question 
 
Will improved delivery of standard case management of pneumonia in district hospitals throughout 
Malawi be accompanied by a decrease in the in-hospital case fatality rates (CFR) from pneumonia 
in children less than 5 years of age? 
 
Research hypothesis 
 
Improved SCM of pneumonia in district hospitals throughout Malawi is associated with a decrease 
in the in-hospital CFR from pneumonia in children less than 5 years of age. 
 
Primary outcome 
 
The primary outcome of the study is in-hospital CFR in children less than 5 years of age in facilities 
that have improved the delivery of SCM of pneumonia.  
 
Study setting  
 
All district hospitals throughout Malawi prior to and over the course of improving SCM of 
pneumonia through the implementation of the CLH Programme.  
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Chapter 2 
 
 
 
The influence of HIV infection on pneumonia standard case management 
 
 
In southern African countries it is estimated that between 35% to 65% of children admitted with 
severe pneumonia are co-infected with HIV and have a higher case fatality rate (34%) than children 
with pneumonia who are HIV negative (9%).  
 
Further, the number of pneumonia deaths may be underestimated in malaria-endemic and HIV-
endemic countries because of the common problem of clinical overlap.  
 
Penny M Enarson, Robert P Gie, Donald A Enarson, Charles Mwansambo, Stephen M 
Graham. Impact of HIV on standard case management for severe pneumonia in 
children. Expert Rev. Resp. Med. 4(2), 211–220 (2010).2 
 
 
 
This review describes how HIV infection is likely to have a major impact on current WHO 
recommendations for the standard case management of pneumonia in children.  The identified 
studies indicated an overall six fold (range 2.5–13.5-fold) increase in pneumonia-related fatality in 
HIV-infected compared with HIV-uninfected African infants and children and that are more likely to 
have disease due to mixed infection and from a wider range of pathogens including Pneumocystis 
jiroveci, Mycobacterium tuberculosis and cytomegalovirus. 
 
 
 
                                               
2 Reprinted with permission of the Expert Review Respiratory Medicine Journal. 
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Chapter 3 
 
Oxygen an essential medicine 
Hypoxia is common in children with respiratory disease and is associated with significant morbidity 
and mortality. Recent work has shown that improved management of hypoxia can markedly reduce 
pneumonia-related mortality. While the mechanism is clear, the real challenge is implementation of 
improved hypoxia management systems in many health facilities in resource-limited setting. This 
includes more accurate detection of hypoxia using oximetry as well as effective delivery of oxygen. 
This article challenges the following misconceptions about the use of oxygen therapy in low 
income/resource countries: The burden of hypoxaemia is small and does not justify its inclusion as 
a public health issue; oxygen therapy is too expensive or too complicated to implement; it is 
palliative and does not improve rates of cure; there is a lack of evidence of effectiveness; and it is 
not cost-effective.  
 
T. Duke, S. M. Graham, M. N. Cherian,  A. S. Ginsburg, M. English, S. Howie, D. 
Peel, P. M. Enarson, I. H. Wilson, W. Were; the Union Oxygen Systems Working 
Group. Oxygen is an essential medicine: a call for international action. Int J 
Tubercs Lung Dis 2010;14(11):1362–1368.3 
 
Improving access to oxygen and pulse oximetry has demonstrated a reduction in mortality from 
childhood pneumonia by up to 35% in high-burden child pneumonia settings and is an entry point 
for improving the quality of care. 
 
 
                                               
3 Reprinted with permission of the International Union Against Tuberculosis and Lung Disease. Copyright © The Union. 
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Chapter 4 
 
 
The challenges to improving standard case management at inpatient level 
 
 
Up to 20% of children assessed at primary level Integrated Management of Childhood Illnesses 
(health centres) require referral to the next level for admission with severe/very severe 
pneumonia/disease.  A number of studies have identified that there are major problems at these 
facilities including lack of triage, poor assessment and knowledge of standard case management 
strategies, late or missed treatment, inadequate supplies of drugs and oxygen and little if no 
regular monitoring or reassessment of severely ill children.  If we are to achieve the MDG 4 then 
these deficiencies in the quality of inpatient paediatric care in resource poor countries must be 
addressed.   
 
 
Stephen M Graham, Mike English, Tabish Hazir, Penny Enarson,Trevor Duke. 
Challenges to improving case management of childhood pneumonia at health 
facilities in resource-limited settings. Bulletin of the World Health Organization 
2008;86:349–355.4 
 
This review focuses on the major challenges and uncertainties relating to case-management 
guidelines in a variety of settings; and the issue of implementation in resource-limited settings. It 
highlights issues relating to pneumonia management at health facilities that require further 
evidence to improve effectiveness of case-management guidelines in different settings. It 
addresses the particular challenges encountered in regions of high case-fatality rate where 
bacterial pneumonia is common in young infants and where comorbidities such as HIV infection 
and malnutrition are common. The review concludes that even in such settings, implementation of 
SCM guidelines can substantially reduce pneumonia-related mortality because many health 
facilities still lack the basic needs for effective case management: evidence-based training, 
facilitated referral, antibiotics and oxygen. 
 
 
                                               
4 Reprinted with permission of the Bulletin of the World Health Organization. 
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Chapter 5a 
 
Development and Implementation of a National Programme for the 
Management of Severe and Very Severe Pneumonia 
 
More attention and support need to be given to actions to improve hospital care for children. 
Improving hospital systems that deliver better care for children will have an impact more widely on 
other hospital services, support first-level IMCI services and strengthen links with local 
communities, all of which should result in better utilization of health services at all levels. The 
challenges remain to bring these and other strategies to scale and to support research into their 
use, impact and sustainability in different environments. This relatively inexpensive intervention 
(SCM) is effective and with universal coverage it is calculated that 65% of pneumonia deaths can 
be prevented but this approach has not been implemented on a large scale and the effect of this 
intervention accurately evaluated.  The problem is that in most low-income countries – Malawi for 
example - the health service delivery mechanism was unable to deliver this intervention to a 
sufficient number of children at a level of quality and coverage that would result in a significant 
impact. A distinction needs to be drawn between the interventions for child survival that are known 
to be effective (e.g. SCM for pneumonia) and the “delivery strategy” by which to deliver these 
strategies to the child at risk.   
 
Enarson PM, Gie R, Enarson DA, Mwansambo C (2009) Development and 
Implementation of a National Programme for the Management of Severe and 
Very Severe Pneumonia in Children in Malawi. PLoS Med 6(11): e1000137. 
doi:10.1371/journal.pmed.1000137 Published November 10, 2009. 
 
This article describes the development and scaling-up of a country-wide delivery strategy of SCM 
for pneumonia in children in Malawi. Expansion was designed to achieve the widest possible 
access to the CLHP in the shortest time whilst maintaining quality. By the end of the fourth year, all 
twenty two district and three central hospitals had been included. Between 1 October 2000 and 31 
December 2005 they reported 48,702 pneumonia cases admitted. During this period the proportion 
of children dying of pneumonia fell from 18.6% to 8.4%, a reduction of 54.8% over the baseline. 
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Chapter 5b 
Implementation of an oxygen concentrator system in  
district hospital throughout Malawi 
 
Recent studies have found that effective implementation of these systems is more cost-effective 
than is usually perceived, and comparable in terms of cost to other already established major 
public health interventions for children. In order to assist with addressing these issues, health 
workers and administrators need information to help procure and maintain equipment, select the 
most robust and reliable products, and also to have data that makes a clear case for the 
investment in such systems. Effective implementation requires not just equipment but some 
training and a team approach that includes a range of expertise.  
 
 
Penny Enarson, Sophie La Vincente, Robert Gie, Ellubey Maganga & 
Codewell Chokani. Implementation of an oxygen concentrator system in 
district hospital paediatric wards throughout Malawi. Bulletin of the World 
Health Organization 2008;86:344–348.5 
 
 
This article describes the implementation of an oxygen system throughout Malawi based on 
oxygen concentrators to address the problem of hypoxaemia in children with severe pneumonia 
admitted to inpatient paediatric wards at District hospital level.  The major finding from this process 
is that it is feasible to deliver oxygen countrywide at district hospital level in low-income countries 
through oxygen concentrators fitted with flow-splitters. Major challenge identified was the high 
staff-turnover rates among trained nurses and clinical officers, resulting in the need for regular 
ongoing training of new staff. 
 
 
 
 
                                               
5 Reprinted with permission of the Bulletin of the World Health Organization. 
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Chapter 6 
 
Reducing deaths from severe pneumonia in children in Malawi by 
improving delivery of pneumonia case management. 
 
The technical rationale supporting the CLHP was that the standard case management of children 
with pneumonia by trained staff with a regular supply of effective antibiotics should result in a 
significant decline of deaths in district hospitals. It was also foreseen that the impact would be 
detectable after some months of project implementation once the guidelines and procedures have 
been efficiently put into practice. 
 
Penny Enarson, Robert Gie, Charles Mwansambo, Ellubey Maganga, Carl 
Lombard, Donald Enarson, Stephen Graham. Reducing deaths from severe 
pneumonia in children in Malawi by improving delivery of pneumonia case 
management. PLoS ONE 9(7): e102955. doi:10.1371/journal.pone.0102955. 
Published July 22, 2014. 
 
A prospective nationwide public health intervention study to evaluate the impact on pneumonia 
specific CFR in infants and young children (0 to 59 months of age) following the implementation of 
a Child Lung Health Programme (CLHP) within paediatric inpatient wards in  24 of 25 district 
hospitals in Malawi.  Following implementation, 47,228 children were admitted to hospital for 
severe/very severe pneumonia with an overall CFR of 9•8%. The majority (64%) of cases, 2-59 
months, had severe pneumonia. In this group there was a significant effect of the intervention 
Odds Ratio (OR) 0•70 (95%CI: 0•50-0•98); p=0•036), while in the same age group children treated 
for very severe pneumonia there was no interventional benefit (OR 0•97 (95%CI: 0•72–1•30); 
p=0•8). No benefit was observed for neonates (OR 0•83 (95%CI: 0•56–1•22); p=0•335). The 
results of this study were derived from the information system implemented to collect routine data 
which produced a very comprehensive and complete set of routine data collected over the duration 
of the study. Further research is required to establish the reasons for the lack of benefit for 
neonates, infants and children with very severe pneumonia. 
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Chapter 7 
 
Potentially modifiable factors associated with death of infants and children with severe 
pneumonia routinely managed in district hospitals in Malawi. 
 
The previous study based on the aggregate data did show a significant reduction of CFR in 
children two to fifty-nine months of age with severe pneumonia but not for the same age group with 
very severe pneumonia or for infants less than two months of age.  To investigate the reasons for 
this poor outcome we undertook further research of a subset of this cohort to determine the 
individual factors including demographics of the study population, recognised co-morbidities and 
clinical management that were associated with inpatient death.   
 
Penelope M Enarson, Robert P Gie, Charles C Mwansambo,  Alfred Chalira, 
Norman Lufesi, Ellubey R Maganga, Donald A Enarson, Neil A Cameron, 
Stephen M Graham. Potentially modifiable factors associated with death of 
infants and children with severe pneumonia routinely managed in district 
hospitals in Malawi. 
Submitted for publication 26/09/2014. 
 
The subset included all children aged 0-59 months admitted with severe and very severe 
pneumonia to the paediatric wards in the first sixteen district hospitals throughout Malawi between 
1st October 2000 and 30th June 2003. We compared individual factors between those that survived 
(n = 14 076) and those that died (n = 1 633) with an overall CFR of 10.4%. Very severe pneumonia 
was associated with a significantly higher CFR than those classified as severe pneumonia.  The 
lack of intervention effect in infants and children younger than 59 months suffering from very 
severe pneumonia is similar to other studies from the African region even when the studies have 
been conducted in central hospitals that have better resources than district hospitals. 
 
We were surprised to discover the extent of misclassification in this group of patients as we had 
previously concluded that standard case management was an important approach to reduce case 
fatality in this setting.  We were unable to judge the extent of misclassification in our previous study 
(Chapter 6) because we reported only aggregate data from routine reports.  It was only when we 
analysed individual data in this part of the study that we were able to determine the extent of the 
misclassification, hence justifying the importance of analysing individual data in addition to 
reporting the results from analysis of aggregate data. 
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Abstract 
 
Objective:   To investigate recognised co-morbidities and clinical management associated with 
inpatient pneumonia mortality. 
 
Methods: Prospective cohort study, of patient records, carried out in Malawi between 1st October 
2000 and 30th June 2003.  The study included all children aged 0-59 months admitted to the 
paediatric wards in sixteen district hospitals throughout Malawi with severe and very severe 
pneumonia. We compared individual factors between those that survived (n = 14 076) and those 
that died (n = 1 633) 
 
Results: From logistic regression analysis, predictors of death in hospital, adjusted for age, sex 
and severity grade included incorrect antibiotic administered (OR = 2.27, 95% CI 1.91-2.70), 
comorbid conditions of meningitis (OR = 2.96, 95% CI 1.89-4.64), malnutrition (OR = 2.83, 95% CI 
2.36-3.40) and severe anaemia (OR =1.61, 95% CI 1.29-2.01). Receiving oxygen (OR = 2.12, 95% 
CI 1.86-2.41) and intravenous therapy (OR = 3.71, 95% CI 2.69-5.11) were associated with death 
while blood transfusion was no longer significant (OR = 1.05, 95% CI 0.75-1.46) when the model 
included severe anaemia. 
 
Conclusions: This study identified a number of challenges to improve outcome for Malawian 
infants and children hospitalised with pneumonia. These included improved assessment of co-
morbidities and more rigorous application of standard case management. 
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Introduction 
Pneumonia is consistently estimated to be the single major cause of death in infants and young 
children (1-59 months of age) and almost all these deaths occur in low-income countries. [1-3] It is 
estimated that approximately 50% of all deaths due to pneumonia in children occur in sub-Saharan 
Africa. [4] However, there are a number of acknowledged limitations to attributing a death to a 
single disease entity. [5-7] First, in infants and young children with severe pneumonia, co-
morbidities such as malnutrition or HIV infection are common and increase the risk of death. [8,9] 
Second, there is clinical overlap with diseases such as severe anaemia, malaria or septicaemia 
that may result in death being wrongly attributed to pneumonia. [10,11] Finally, it is also recognised 
that bacterial pneumonia can occur as a co-infection or secondary complication in children with 
other infections such as measles, severe malaria or tuberculosis. [12-14] Nonetheless, health 
workers in high mortality settings are required to manage sick children according to standard case-
management protocols on the basis of clinical findings with very limited diagnostic support.  
 
We recently reported outcomes from a prospective implementation programme that included 
47,228 Malawian children admitted to district hospitals in Malawi for severe and very severe 
pneumonia over a five year period. [15,16] We have further analysed data from a subset of this 
cohort to determine the individual factors including demographics of the study population, 
recognised co-morbidities and clinical management that were associated with inpatient death. 
 
Methods 
Study participants 
We reviewed the sequential records of all infants and young children (< 5 years) that were 
admitted to one of 16 district hospitals in Malawi between 1st October 2000 and 30th June 2003 as 
part of the Malawi Child Lung Health Programme (CLHP). The Malawi CLHP included a 
prospective evaluation of the implementation of standard case-management for 47,228 children 
admitted with severe or very severe pneumonia to one of the 24 district hospitals in Malawi over a 
5-year period (2000-2005).  
 
The implementation, methodology, evaluation and main outcomes of the Malawi CLHP have been 
described in detail in previous publications. [15,16] Briefly, all neonates, infants and young children 
between 0 and 59 months of age hospitalised with a clinical diagnosis of severe or very severe 
pneumonia, according to WHO definitions at the time, were included. The implementation followed 
training of staff to follow the recommended WHO pneumonia standard case management 
approach (Box 1) and it was ensured that supplies of treatment for child pneumonia (i.e. 
recommended antibiotics and oxygen therapy) were available. 
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Study procedures 
All children included in the Malawi CLHP were allocated a “Pneumonia Inpatient Recording Form” 
which prospectively collected relevant data including demographic data, clinical data including 
weight, classification of severity of pneumonia, detailed data of management, and outcome data. In 
addition to training on the WHO standardised case-management approach to child pneumonia, 
staff were also trained on the diagnosis and management (according to national guidelines) of 
other related causes of common childhood illness such as malaria, anaemia or malnutrition.  
 
The diagnosis and investigation of co-morbidities depended on clinical suspicion and usually 
clinical diagnosis. In addition, a thick blood film was examined for Plasmodium falciparum malaria 
diagnosis, or a haematocrit or haemoglobin were determined for diagnosis of anaemia. Chest 
radiography was not carried out on admission routinely but was only used in those cases not 
responding to first-line antibiotics. No diagnostic tools were available or used to determine 
aetiological pathogen(s) causing pneumonia such as bacteria, viruses or fungi such as 
Pneumocystis jirovecii. Testing for HIV infection was rarely undertaken at the time of this study.     
 
Weight was plotted for age on the Road to health card, and severe malnutrition was diagnosed if 
there was severe wasting or nutritional oedema. Severe malaria was diagnosed clinically in 
children with altered consciousness and/or convulsions 
 
Data management 
Data from the Inpatient Recording Forms were double entered into an ACCESS® database, and 
then transferred to EXCEL® for cleaning. The following variables were selected for analysis: age, 
sex, classification of severity of pneumonia, any recorded comorbid conditions (included malaria, 
malnutrition, severe anaemia, meningitis and sepsis), origin of referral (self or transfer from a 
primary health care centre), antibiotic use prior to admission, and treatment given. See Table 1 for 
frequency of variables. Pneumonia classification and antibiotic therapy were determined as correct 
or incorrect according to standardised case-management using clinical data available by the study 
investigators at the time of review.  
 
Statistical Analysis 
Data were analysed using SPSS, version 7.5 for Windows and web-based OpenEpi (version 2.3). 
Because of the large sample size an effect size was arbitrary set at <0.67 and >1.5 to determine 
the importance of the odds ratio (OR). A univariate analysis was run to find the distribution and 
mortality rates for the different variables using chi-square test. A probability level of <0.05 was 
considered significant and was used for inference. 
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Both univariate and logistical regression analysis were performed to determine the association 
between variables by estimating the odds ratio (OR) and 95% Confidence Intervals (CI) were 
calculated.  Logistical regression was run to measure the independent effects of the significant 
variables on outcome - the proportion of the children who died while in hospital or case-fatality rate 
(CFR) was the primary outcome indicator measured.  The Odds Ratio (OR) and 95% Confidence 
Intervals (CI) were calculated to estimate the risk adjusting for potential confounders.   
 
Ethical considerations 
The CLHP was routine patient management and data from it was routinely collected. Patient 
identifiers such as names, geographic location by sub-district, patient registration number and 
specific date (except month and year) of admission were not included in database. Permission to 
use the data was received from the Ministry of Health, Republic of Malawi. Approval to analyze the 
data was obtained from the Union’s Ethical Advisory Group (EAG: 05/10) and the Human 
Research Ethics Committee (N10/09/285), Faculty of Medicine and Health Sciences, Stellenbosch 
University.   
 
Results 
A total of 17,585 of infants and young children were admitted with pneumonia in the 16 district 
hospitals and 17,480 (99.4%) records were available for analysis. From these, 1771 were excluded 
for reasons shown in the study flow chart in Figure 1; 15,709 children were included in the final 
analysis. The age distribution of this group is shown in Figure 2. There were 1633 deaths in this 
cohort with an overall CFR of 10.4%. Very severe pneumonia was associated with a significantly 
higher CFR than those classified as severe pneumonia (Figure 3). 
 
Table 1 lists management characteristics of the study group and compares CFR according to these 
variables by calculating odds ratios. The majority (76.8%) of admissions were self-referred and 
children who were self-referred were less likely to receive an antibiotic prior to admission as 
compared to those referred from a primary health care centre (17.0% compared to 55.0%: 
p<0.001).  Self- referral was associated with a significantly lower CFR than referral from a primary 
health centre but prior use of antibiotic was not.  
 
A total of 5183 (33.0%) were misclassified according to severity grade. Incorrect classification on 
admission varied across age groups and severity grades. For very severe pneumonia, the 
numbers and proportions misclassified were:  118 (12.6%) for < 2 months, 1509 (61.6%) for 2-11 
months, and 135 (8.3%) for 12-59 months, and for severe pneumonia, 500 (69.0%), 2268 (39.8%) 
and 653 (15.3%) respectively.   
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Table 2 shows that 5493 (35.1%) children received an incorrect antibiotic with the majority 
occurring in those incorrectly classified (4559, 88.6%) whereas if children were correctly classified 
the number receiving the wrong antibiotic was less (934, 8.9%).  Giving an incorrect antibiotic 
when the correct classification was made was most frequent in those with very severe pneumonia 
who were 2 to 11 months of age (102, 10.9%) and those 12 to 59 months of age (269, 18.1%). 
Figure 4 illustrates that for all categories of age group and severity grade, those who were given an 
incorrect antibiotic were more likely to die.     
  
Table 3 shows logistic regression analysis of predictors of death in hospital, adjusted for age, sex 
and severity grade. Type of referral, and receiving an antibiotic prior to admission were not 
associated with death.  Incorrect classification of severity grade was significantly associated with 
death (OR = 1.22, 95% CI 1.09-1.37). The addition of receiving an incorrect antibiotic into the 
model demonstrated a significant association with death (OR = 2.27, 95% CI 1.91-2.70).  In this 
model, the previously demonstrated increased risk of death with incorrect classification of severity 
grade was no longer demonstrated.    
 
Comorbid conditions were present on admission in 6 541 (61.2%) of severe pneumonia cases and 
in 2 806 (56.5%) of very severe pneumonia cases.  Malaria was the most frequent comorbid 
condition being diagnosed in 8 013 (51.0%) of cases. Table 1 shows the results of analysis of CFR 
associated with comorbid conditions. A diagnosis of meningitis, malnutrition or severe anaemia 
was associated with death, and these all remained significant associations following logistic 
regression analysis adjusted for age, sex, severity grade and additional treatment (Table 3). CFR 
for those with a clinical diagnosis of sepsis was higher than for those without but this was not a 
statistically significant difference. The CFR for those with malaria was similar to that in those 
without malaria.  
 
Table 1 shows additional treatment modalities. The most frequent were receiving antimalarials 6 
288 (40.0%) or oxygen therapy 1 954 (12.4%). Those who were treated with antimalarials had a 
lower CFR than those that did not, while those receiving other additional treatments, including 
intravenous fluids, oxygen therapy and blood transfusion had a significantly higher CFR. On 
logistic regression analysis, oxygen or intravenous therapy remained significantly associated with a 
higher CFR while anti-malarial therapy was associated with a significantly lower CFR.  
 
There were 621 children diagnosed with severe anaemia of whom 399 (64.3%) received a blood 
transfusion and experienced a 13.0% CFR.  Those 222 (35.7%) not receiving a blood transfusion 
had a much higher CFR 27.5% (OR 2.52, 95% CI 1.67-3.83).  Receiving a blood transfusion was 
Stellenbosch University  https://scholar.sun.ac.za
 
 
 
 
103 
no longer a significant predictor of death when the model included severe anaemia (Table 4).  
Malaria comorbidity became statistically significant (OR = 1.18, 95% CI 1.03-1.36) when anti-
malarials were included in the model (Table 5).  
 
Discussion 
We found a high mortality in a large cohort of 15,709 Malawian infants and children with severe 
pneumonia managed in 16 district hospitals. The CFR is similar to that previously reported for an 
even larger cohort of which this group reported here represent a sub-set. [16] The majority of cases 
presented to the hospital directly. Initial classification of severity and therefore use of first-line 
antibiotic therapy were incorrect in one-third of cases overall and higher than this in those with very 
severe pneumonia. The commonest co-morbidity was malaria which was diagnosed in half of the 
cases. Features associated with an increased pneumonia-related mortality were the severity of 
pneumonia, the presence of co-morbidities such as malnutrition, severe anaemia or meningitis, 
and the incorrect classification and therefore treatment of child pneumonia cases. While none of 
these associations is unexpected, the unique characteristic of the study is that these features have 
been analysed following prospective and complete clinical data collection from children managed 
under routine conditions at a district hospital level in a high mortality setting.  
 
While data from a routine setting is a strength of the study, there are a number of important 
limitations that must be acknowledged. A major limitation of our study was that HIV prevalence 
data were not available for this cohort. While health workers were trained to recognise and treat 
Pneumocystis jirovecii pneumonia (PcP) and other HIV-related lung disease, this almost certainly 
did not occur as almost all participants’ HIV status was recorded as unknown. The lack of testing 
reflected both a lack of policy of routine testing in children with severe pneumonia, and a lack of 
willingness by health workers to undertake testing due to stigma compounded by a lack of access 
to anti-retroviral therapy at the time of the study. However, the potential importance of HIV as a 
common co-morbidity in Malawian infants and children with severe pneumonia that had an impact 
on aetiology and outcome is recognised from studies reported from urban-based tertiary hospitals 
in Malawi and the region. [9] PcP is a common and often fatal cause of severe or very severe 
pneumonia in HIV-infected Malawian infants, especially between 2 and 6 months of age, and is 
likely to have contributed to the age-related mortality that was noted (Figure 3). [17,18]  
 
The other major limitation is that the diagnosis of other co-morbidities in this study was usually 
clinical without laboratory confirmation such as for malaria, sepsis or severe anaemia. Therefore, it 
cannot be determined whether these conditions were under-diagnosed or over-diagnosed, 
especially as there is clinical overlap with severe pneumonia. [19] Further, while recognised as co-
morbidities that can influence outcome, the evidence of association for this study is weakened by 
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the lack of laboratory confirmation. Similarly, malnutrition is a major recognised co-morbidity that 
increases pneumonia incidence and mortality, [5,7,8] but objective measure of nutritional status 
such as weight-for-age has not been determined for this cohort.   
 
It is interesting to note that those that received antibiotics prior to admission had worse outcomes. 
However, while this may appear to be a surprising finding, there is evidence to suggest that this 
may have reflected severity of disease and health-seeking behaviour rather than the use of 
antibiotic before referral per se. Those that attended and received an antibiotic at a primary care 
facility prior to admission to the district hospital had more severe disease, and severity of disease 
is strongly associated with outcome. We were also not able to determine other related issues of 
access to care or distance from facilities, or other socio-economic or behavioural factors that also 
determine use of care facilities and duration of symptoms before presentation. 
 
Previous studies have noted major deficiencies with quality of care at the district hospital setting in 
many resource-limited settings. [20-22] Quality of care along with ready availability of effective 
therapy such as antibiotics and oxygen have an impact on outcome. [23] Efforts were made to 
minimise the impact of these important potential confounders on outcomes in this study population. 
This study was undertaken following training of health workers on standardised case management 
as well as ensuring provision of an uninterrupted supply of antibiotics and oxygen therapy. 
However, despite a one-week training course, large numbers of children were still incorrectly 
classified. One issue that could not be addressed was the low staff numbers and the high turnover 
in all settings. [14]  
 
It was noted that the provision of oxygen therapy, intravenous fluids or blood transfusion were all 
independently associated with a significantly higher CFR. The use of these therapies are all likely 
indicators of the severity of pneumonia and the presence of co-morbidities. Severity of hypoxaemia 
in children with pneumonia is associated with an increased risk of death. [24] There is clear 
evidence that oxygen therapy improves outcome in children with severe pneumonia, and that the 
routine use of oximetry improves effectiveness of oxygen therapy as it is more sensitive and 
specific for identifying hypoxaemic children than clinical indicators. [25] It is likely that in our study, 
the most hypoxaemic children were selected for oxygen therapy as pulse oximetry was not 
routinely available in this study and clinical indicators were relied upon. This is supported by the 
observation that mortality was higher in those that received oxygen, which reflects severity rather 
than impact of oxygen. The poor outcome in those receiving oxygen also suggests that PcP was 
not uncommon in this cohort. [23] 
 
Stellenbosch University  https://scholar.sun.ac.za
 
 
 
 
105 
This study has identified several co-morbidities such as malnutrition and severe anaemia for which 
prevention is called for to improve the health of these vulnerable children.  It also identified a 
number of potentially modifiable aspects of care where adjustments to the implementation of SCM 
are indicated.  These include  enhancing correct classification of the severity of the disease, the 
use of correct antibiotics according to standard case management, more extensive availability and 
use of oxygen together with oximetry to guide its use, universal testing for HIV and more routine 
use of simple laboratory tests to detect malaria and anaemia.  To improve the outcome of these 
children with pneumonia, structural improvements are needed to address these needs. In addition, 
more comprehensive training to deal with co-morbid conditions might improve the quality of care.  
Further research is needed to investigate the process of transfer to hospital through the primary 
services and to demonstrate how laboratory services could be more efficiently used.   
 
In conclusion, pneumonia-related mortality is common in Malawian infants and children cared for in 
the routine care hospital setting. Reducing mortality might be achieved through improved 
assessment, more rigorous application of standard case management and more accurate 
identification and effective management of co-morbidities.   
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16 546 
Imported into EXCEL for cleaning 
934 entries removed as insufficient data recorded on treatment cards 
especially classification and outcome 
16 411 
 
421 entries removed  
of non-severe pneumonia category  
 
135 duplicated entries removed 
 
16 130 
 
 
15 709 Entries to be analysed 
 
281 entries removed of retreatment  
following treatment failure 
 
17 480 records 
entered into ACCESS Database 
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Figure 2. Age distribution of consecutive children (0-59 months) treated for pneumonia in district 
hospitals in Malawi, 2000-2003 
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Figure 3. Case fatality rate of consecutive children (0-59 months) treated for pneumonia in district 
hospitals in Malawi, 2000-2003 by severity grade.  
 
 
 
 
 
 
 
For ease of comparison the children were sorted by age and then divided into ten equal groups (deciles). Consequently 
each of the ten deciles contains an equal number of children. 
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Figure 4. Case fatality rate of consecutive children (0-59 months) treated for pneumonia in district 
hospitals in Malawi, 2000-2003 by age, severity grade and antibiotic regimen. 
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Table 1. Distribution and CFR of consecutive children (0-59 months) treated for pneumonia in 
district hospitals in Malawi, 2000-2003 from univariate analysis.   
 
Variable Category Number 
of cases 
% of 
total 
CFR% Crude 
Odds 
ratio 
95% 
confidence 
interval 
      lower upper 
 All 
children 
15,709  10.4    
        
Management        
Type of referral Self 12062 76.8 9.5    
 HC 2441 15.5 13.8 0.65 0.57 0.74* 
 Unknown 1206 7.7     
Antibiotic prior No 12288 87.2 10.1 0.88 0.78 0.99 
to admission Yes 3421 21.8 11.4    
Correct 
Classification 
No 5183 33.0 12.3 1.35 1.21 1.49 
as per SCM Yes 10526 67.0 9.4    
Correct Antibiotic No 5493 35.0 14.1    
as per SCM Yes 10137 64.5 8.4 1.79 1.62 1.99 
 Unknown 79 0.5     
        
Comorbidity        
Malaria Yes 8,013 51.0 9.6 0.84 0.76 0.93 
 No 7,696 49.0 11.2    
Malnutrition Yes 826 5.3 23.2 2.83 2.38 3.35 
 No 14,883 94.7 9.7    
Severe anaemia Yes 621 4.0 18.2 1.99 1.61 2.45 
 No 15,088 96.0 10.1    
Sepsis Yes 99 0.6 16.2 1.67 0.97 2.86 
 No 15,610 99.4 10.4    
Meningitis Yes 93 0.6 35.5 4.82 3.14 7.39 
 No 15,616 99.4 10.2    
        
Additional treatment        
Oxygen Yes 1954 12.4 28.5    
 No 13754 87.6 7.8 4.68 4.17 5.26 
 Unknown 1 0.0     
IV fluids Yes 191 1.2 41.4 6.43 4.73 8.49 
 No 15518 98.8 10.0    
Antimalarials Yes 6288 40.0 8.6    
 No 9420 60.0 11.6 0.71 0.62 0.79 
 Unknown 1 0.0     
Blood  Yes 494 3.1 16.8 1.78 1.39 2.27 
transfusion No 15215 96.9 10.2    
 
CFR: case-fatality rate; SCM: standard case-management 
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Table 2. Association between classification and antibiotic use in consecutive children (0-59 
months) treated for pneumonia in district hospitals in Malawi, 2000-2003 
 
 
 
severity age group classification all Incorrect antibiotic 
    No. % 
severe <2 correct 223 7 3.1% 
  
incorrect 496 24 4.8% 
 
2 to 11 correct 3422 229 6.7% 
  
incorrect 2261 2261 100.0% 
 
>11 correct 3603 318 8.8% 
  
incorrect 644 644 100.0% 
very severe <2 correct 813 9 1.1% 
  
incorrect 118 1 0.8% 
 
2 to 11 correct 938 102 10.9% 
  
incorrect 1502 1502 100.0% 
 
>11 correct 1483 269 18.1% 
 
  incorrect 127 127 100.0% 
All cases 
 
correct 10482 934 8.9% 
    incorrect 5148 4559 88.6% 
Total     15630 5493 35.1% 
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Table 3. Odds ratios from logistic regression models for mortality on management and comorbidity 
covariates adjusted for age, sex and severity grade of consecutive children (0-59 months) treated 
for pneumonia in district hospitals in Malawi, 2000-2003. 
 
Model Variable Odds Ratio 95% Confidence Limit 
   Lower Upper 
1 Age 0.99 0.98 0.99 
 Sex 1.12 1.00 1.25 
 Severity Grade 5.26 4.69 5.91 
 Type of referral 0.70 0.60 0.80 
 Prior Antibiotic 1.02 0.89 1.17 
     
2 Age 0.99 0.98 0.99 
 Sex 1.10 0.98 1.23 
 Severity Grade 5.20 4.66 5.81 
 Incorrect Classification 1.22 1.09 1.37 
     
3 Age 0.98 0.98 0.99 
 Sex 1.10 0.99 1.23 
 Severity Grade 5.03 4.50 5.62 
 Incorrect Classification 0.63 0.52 0.75 
 Incorrect Antibiotic 2.27 1.91 2.70 
     
4 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 5.19 4.65 5.80 
 Malaria 0.95 0.85 1.06 
     
5 Age 0.98 0.98 0.99 
 Sex 1.10 0.98 1.22 
 Severity Grade 5.11 4.57 5.71 
 Malnutrition 2.83 2.36 3.40 
     
6 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 5.13 4.60 5.74 
 Severe Anaemia 1.61 1.29 2.01 
     
7 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 5.21 4.66 5.82 
 Sepsis 0.92 0.53 1.61 
     
8 Age 0.99 0.98 0.99 
 Sex 1.09 0.98 1.22 
 Severity Grade 5.14 4.60 5.74 
 Meningitis 2.96 1.89 4.64 
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Table 4. Odds ratios from logistic regression models for mortality on comorbidity and additional 
treatment covariates adjusted for age, sex and severity grade of consecutive children (0-59 
months) treated for pneumonia in district hospitals in Malawi, 2000-2003. 
 
Model Variable Odds Ratio 95% Confidence Limit 
   Lower Upper 
1 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 3.83 3.39 4.32 
 O2 2.12 1.86 2.41 
 IV 3.71 2.69 5.11 
 Antimalarials 0.77 0.68 0.86 
 Blood transfusion 1.47 1.13 1.91 
2 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 3.81 3.37 4.31 
 Malaria 1.21 1.05 1.39 
 O2 2.15 1.88 2.45 
 IV 3.68 2.67 5.07 
 Antimalarials 0.67 0.58 0.78 
 Blood transfusion 1.46 1.12 1.90 
3 Age 0.98 0.98 0.99 
 Sex 1.10 0.98 1.22 
 Severity Grade 3.74 3.31 4.23 
 Malnutrition 2.85  2.37 3.43 
 O2 2.16 1.89 2.46 
 IV 3.53 2.56 4.87 
 Antimalarials 0.76 0.68 0.86 
 Blood transfusion 1.46 1.12 1.90 
4 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 3.79 3.36 4.29 
 Severe Anaemia 1.63 1.21 2.18 
 O2 2.12 1.86 2.42 
 IV 3.73 2.71 5.14 
 Antimalarials 0.75 0.67 0.84 
 Blood transfusion 1.05 0.75 1.46 
5 Age 0.99 0.98 0.99 
 Sex 1.10 0.99 1.22 
 Severity Grade 3.83 3.39 4.33 
 Sepsis 0.89 0.51 1.56 
 O2 2.12 1.86 2.41 
 IV 3.71 2.69 5.11 
 Antimalarials 0.76 0.68 0.86 
 Blood transfusion 1.47 1.13 1.91 
6 Age 0.99 0.98 0.99 
 Sex 1.10 0.98 1.22 
 Severity Grade 3.78 3.34 4.27 
 Meningitis 2.92 1.83 4.65 
 O2 2.12 1.86 2.42 
 IV 3.64 2.64 5.02 
 Antimalarials 0.76 0.67 0.85 
 Blood transfusion 1.46 1.12 1.90 
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Table 5. Odds ratios from logistic regression models for mortality on malaria and additional 
treatment covariates with and without anti-malarials adjusted for age, sex and severity grade of 
consecutive children (0-59 months) treated for pneumonia in district hospitals in Malawi, 2000-
2003. 
 
Model Variable Odds Ratio 95% Confidence Limit 
   Lower Upper 
With anti-malarials    
 Age  0.98 0.98 0.99 
1 Sex 1.10 0.98 1.22 
 Classification 3.67 3.24 4.14 
 Malaria 1.18 1.03 1.36 
 Malnutrition 2.82 2.34 3.39 
 Severe anemia 1.49 1.11 2.01 
 Sepsis 0.82 0.47 1.45 
 Meningitis 2.89 1.81 4.59 
 Oxygen therapy 2.19 1.92 2.51 
 Intravenous fluids 3.44 2.48 4.76 
 Antimalarials 0.67 0.58 0.78 
 Blood transfusion 1.10 0.78 1.54 
     
Without anti-malarials    
 Age  0.98 0.98 0.99 
2 Sex 1.10 0.98 1.22 
 Classification 3.72 3.29 4.20 
 Malaria 0.93 0.83 1.04 
 Malnutrition 2.82 2.35 3.40 
 Severe anemia 1.44 1.07 1.94 
 Sepsis 0.83 0.47 1.47 
 Meningitis 2.89 1.82 4.60 
 Oxygen therapy 2.16 1.89 2.47 
 Intravenous fluids 3.33 2.41 4.60 
 Blood transfusion 1.04 0.74 1.45 
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Box 1. WHO standard case management of pneumonia defined by age groups and severity of 
disease 
 
Standard Case Management 
 
Diagnosis 
 
Presenting signs and symptoms Recommended treatment regimens 
Child 2-59 months 
 
Severe pneumonia Respiratory rate (bpm): 
 ≥ 50 aged 2 –11 months 
 ≥ 40 aged 12 – 59 months 
Lower chest wall indrawing 
 
Penicillin  50 000 units/kg 6 hourly for 3 
days if improved then oral amoxicillin 25 
mg/kg three times daily for total of 5 to 8 
days 
Very severe 
pneumonia 
Respiratory rate (bpm): 
 ≥ 50 aged 2 –11 months 
 ≥ 40 aged 12 – 59 months 
Lower chest wall in-drawing 
Cyanosis 
Unable to drink 
Reduced level of consciousness 
Grunting (infants) 
 
Chloramphenicol 25 mg/kg 8 hourly for 5 
days if improved then three times daily for 
total of 10 days antibiotic treatment 
Infant <2 months 
 
Severe/Very severe 
pneumonia 
Respiratory rate: 
 ≥ 60 breaths per minute 
Gentamicin 7.5 mg/kg once daily for 8 days 
Penicillin 50 000units/kg 6 hourly for three 
days if improved then oral amoxicillin 25 
mg/kg three times daily for a total of 8 days 
antibiotic treatment 
 
Co-morbid conditions/pneumonia treatment 
 
Pneumonia in 
severely 
malnourished child 
Signs and symptoms for 
severe/very severe pneumonia as 
above. 
PLUS signs and symptoms for any 
of the following: 
 Marasmus 
 Kwashiorkor 
 <60% Weight for Height 
Cotrimoxazole prophylaxis on admission if 
not acutely ill 
Treatment  for severe or very severe 
pneumonia as above  PLUS 
Gentamicin (7.5 mg/kg IM/IV) once daily for 
7 days 
➤If the child fails to improve within 48 hours, 
add Chloramphenicol (25 mg/kg IM/IV 8-
hourly) for 5 days. 
 
Known/suspected 
PcP 
2–6-month-old child with central 
cyanosis  
Hyper-expanded chest 
Fast breathing 
Chest X-ray changes, but chest 
clear on auscultation 
Enlarged liver, spleen, lymph nodes 
HIV test positive in mother or child 
 
Continue first-line antibiotic (such as 
Chloramphenicol) as mixed infection with 
bacteria occurs 
Oral Cotrimoxazole: 120mg three times 
daily if less than 5 kg; 240 mg three times 
daily if 5 kg or more for 21 days 
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Chapter 8 
Discussion 
 
The aim of this dissertation was to address the problem of death from pneumonia in children less 
than five years of age in Malawi. The hypothesis was that improving inpatient care in all district 
hospitals throughout Malawi would be associated with a decrease in the in-hospital CFR.   
 
Standard case management of pneumonia is a relatively inexpensive intervention that is effective 
and with universal coverage, 65% of pneumonia deaths can be prevented.  The challenge was to 
bring this strategy to scale and, in doing so, it was possible to evaluate the use, impact and 
sustainability in a low-income country, such as Malawi, where the health services were unable to 
deliver this intervention to a sufficient number of children at a high enough level of quality that 
would result in a significant impact.  
 
The research of this dissertation is an operational based research model which analyses the 
delivery of the public health intervention (the CLHP), determines limitations in order to provide a 
basis to address these limitations. The research process included reviewing existing knowledge 
and evaluating practice in implementation in a specific setting – Malawi a low-income/resource and 
high HIV/malaria- endemic country in sub-Saharan Africa. 
 
The findings and discussion could be relevant to other low-income/resource and high HIV/malaria- 
endemic country in sub-Saharan Africa where approximately 50% of all deaths due to pneumonia 
in children occur.[1-3] Children in developing countries being treated for pneumonia frequently 
have one or more comorbid conditions which increases their risk of dying.[4-6] This study 
assessed the risk factors, including comorbid conditions, that predicted a fatal outcome for 
pneumonia in children admitted to first level referral hospital.   Besides examining the clinical 
factors involved in SCM we also examined factors related to the quality of curative care at first level 
referral hospitals for children with common, serious diseases that were referred by primary-level 
IMCI.[7,8]    
 
While standard case management of pneumonia has been shown to be an effective strategy in 
reducing pneumonia-related deaths in children <5 years of age, a major challenge is how to deliver 
the strategy to sufficient children that would result in a significant impact on the pneumonia 
mortality rate.  A situation analysis of the quality of inpatient care of children with severe, very 
severe pneumonia in district hospitals prior to the implementation of the CLHP identified the 
following (1) inadequate health-worker skills/inadequate training; (2) inadequate supplies of 
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antibiotics and equipment to administer oxygen therapy; (3) lack of routine supervision and quality 
assurance mechanisms; (4) deficient use of strategic information in hospitals to assist in planning 
services and procurement of essential items and to evaluate quality of care. 
 
There was a need to distinguish between the known effective intervention strategy - SCM for 
pneumonia – and the “delivery strategy” to bring it to the child at risk.[9] This was achieved 
country-wide through the CLHP, based on a public health service delivery framework (the delivery 
strategy), for the surveillance, diagnosis and management of respiratory diseases and major 
comorbidities in children admitted to in-patient paediatric wards in district hospitals. 
 
The CLHP aimed to improve case management of childhood pneumonia in hospital and address 
specific resource barriers.  The activities implemented were: 1) Diagnostic and treatment 
guidelines; 2) Training of clinical staff in the standardized approach to the interventions against the 
targeted diseases; 3) Logistics to purchase and distribute standard drugs thus ensuring 
uninterrupted supplies at the management level of the District Health Office; 4) Recording and 
reporting system providing data on outcomes of the interventions, to enhance reproducibility and 
sustainability; 5) Internal routine supervision and evaluation of the programme by external 
experts/consultants and 6) Mechanisms to assess quality of practice. 
 
We demonstrated that it was feasible to implement both the CLHP and the oxygen concentrator 
system country-wide in Malawi within first-level referral hospitals.  Sustainability beyond the cycle 
of external funding the programmes was ensured by their inclusion in the Essential Health 
Package funded through the Sector Wide Approach. The CLHP has now been maintained for 8 
years since the end of external project funding and is currently being expanded to 16 non-
government hospitals. All components of the programme are still functioning well.[10] 
 
The major strengths of the CLHP were that it was tailored to the address the specific needs of the 
country identified in the situation analysis, was implemented countrywide, and was incorporated 
within country’s existing structure for organisation of health services and was implemented by the 
personnel already working within these services.  Such personnel already carried out existing 
activities for control of acute respiratory infections and the programme for the integrated 
management of childhood illnesses.  Other important strengths were the prevention of antibiotic 
stock outs and the comprehensive and complete set of data collected over the duration of the 
intervention which enabled us to conduct a comprehensive prospective study to evaluate the 
pneumonia specific case fatality rate over time following the implementation. Our cohort consisted 
of hospitalized cases representing the more severe spectrum of disease that are more likely to die. 
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This was the first nation-wide, hospital-based programme study to investigate the effectiveness of 
hospital-based SCM on pneumonia-related mortality. 
 
The trend in case fatality rates in infants and young children (0 to 59 months of age) hospitalized 
and treated for severe and very severe pneumonia was evaluated over the course of the 
implementation (63 months) of the CLHP.  Over the study period, 47,228 children were admitted to 
hospital for severe/very severe pneumonia with an overall CFR of 9•8% which, although high, is 
within range of those reported from neighbouring countries.[11-13] The higher case-fatality rate 
associated with young age and very severe pneumonia is expected and consistent with other 
studies.[14-17]    
 
The findings from this study showed that the majority (64%) of cases, 2-59 months, had severe 
pneumonia. In this group there was a significant effect of the intervention (Odds Ratio (OR) 0•70 
(95%CI: 0•50-0•98); p=0•036)), while in the same age group children treated for very severe 
pneumonia there was no interventional benefit (OR 0•97 (95%CI: 0•72–1•30); p=0•8). No benefit 
was observed for neonates (OR 0•83 (95%CI: 0•56–1•22); p=0•335). While data routinely collected 
in the district hospitals after training is a strength an important limitation of this study must be 
acknowledged in that it is based on the analysis of aggregate data and therefor it was not possible 
to determine the factors contributing to the lack of benefit as there was no individual patient clinical 
data recorded on the monthly reports.   
 
Another limitation was that the poor quality of patient records and lack of routine reporting prior to 
implementing the program prevented the use of any data on patient care.  Consequently we used 
the first three months of data collected after training as the baseline for comparison which is likely 
to have underestimated the impact of the intervention. This underestimation is supported by the 
high CFR (10–26%) observed during the situational analysis prior to the implementation of the 
CLHP.  The trend of improved outcomes following the first three months of intervention is 
noteworthy as it suggests sustained improvements in care due to this CLHP approach, rather than 
a temporary improvement only following training as might have been expected. 
 
To investigate the reasons for the poor outcome in infants less than two months of age and those 
with very severe pneumonia reported in the previous study further research of a subset of this 
cohort was carried out to determine the individual factors including demographics of the study 
population, recognised co-morbidities and clinical management that were associated with inpatient 
death.  The subset included all children aged 0-59 months admitted with severe and very severe 
pneumonia to the paediatric wards in the first sixteen district hospitals throughout Malawi between 
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1st October 2000 and 30th June 2003. We compared individual factors between those that survived 
(n = 14 076) and those that died (n = 1 633).   
 
The CFR of 10.4% for this subset is similar to that reported for the larger cohort. The age and 
severity grade distribution is also similar to the larger study with the majority (63.5%) of children in 
the 2-59 month age category with severe pneumonia.  Also very severe pneumonia was 
associated with a significantly higher CFR than those classified as severe pneumonia. 
 
The lack of intervention effect in infants and children 2 to 59 months suffering from very severe 
pneumonia is disappointing but the CFR is similar to other studies from the African region even 
when the studies have been conducted in central hospitals that have better resources than district 
hospitals.[12,13,18] There are a number of reasons that might explain this. 
 
In an HIV/TB-endemic setting, such as Malawi, children with severe pneumonia are commonly co-
infected with HIV and these HIV-infected children have a much higher CFR than children with 
pneumonia who are HIV-uninfected.[19] The highest risk group are infants. HIV-infected infants are 
more likely to have disease due to a wider range of pathogens and mixed infection including 
Pneumocystis jiroveci, Cytomegalovirus, Mycobacterium tuberculosis, Gram-negative bacteria and 
co-infections.[20] The impact of HIV has been reported in studies carried out in hospitals in 
southern Africa which showed that HIV is associated with treatment failure and an increase in 
pneumonia-related fatality.[12,18-20] 
 
 A study carried out by Graham et al. in 2005 assessed the impact of HIV Infection on the aetiology 
and outcome of severe pneumonia in Malawian children admitted to a large urban teaching 
hospital.[13]  Their findings were consistent with other studies in the region. HIV prevalence was 
51%. Of the confirmed bacterial pneumonia the most common bacterial isolates were 
Streptococcus pneumoniae and Salmonella typhimurium.  PcP was confirmed in 16 patients who 
were younger, had more severe and persistent hypoxia with a poorer outcome (CFR 75%) 
compared to those with confirmed bacterial pneumonia (CFR 5%).  The overall CFR was 10% - the 
majority of deaths occurred in infants of 2 to 6 months of age and 57% of deaths were associated 
with PcP.[13] The overall CFR was consistent with our findings despite the high nurse-to-patient 
ratio and clinical monitors available at the tertiary level hospital, the use of antibiotics appropriate to 
local antimicrobial susceptibility and the use of high-dose oral cotrimoxazole if PcP was suspected 
on admission.  
 
The prevalence of HIV among pregnant women at sentinel sites throughout Malawi was very high 
during the study period (19.5%, 19.8% and 16.9% in 2001, 2003 and 2005). The rate of mother to 
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child transmission in 2001 was 26.9%.[21]  In 2004 the estimated percentage of HIV+ pregnant 
women who received a full package of care to prevent mother-to-child transmission (MTCT) of HIV 
was only 2.3%.[21] 
 
The introduction of preventive strategies to reduce maternal and perinatal HIV infection, routine 
testing and the introduction of early HAART to HIV+ pregnant women, not dependent on C4 count, 
has been shown to reduce the risk of new HIV infections in babies.[22] The introduction of 
cotrimoxazole preventive therapy (CPT) to all HIV-exposed children and early introduction of HAART 
have been shown to be effective in reducing the incidence of PcP, hospitalization and pneumonia-
related deaths.[19,23-26]  Violari et al. in a randomized controlled study of infants assigned to 
either deferred or early antiretroviral therapy showed a dramatic decrease (76%) in all-cause early 
infant mortality for severe childhood pneumonia and a reduction of HIV progression by 75% in the 
early therapy group.[27] 
 
A major limitation of the study was that HIV prevalence data were not available for the patients 
treated in the district hospitals. While health workers were trained to recognise and treat 
Pneumocystis jirovecii pneumonia (PcP) and other HIV-related lung disease, this almost certainly 
did not occur as almost all participants’ HIV status was recorded as unknown. The lack of testing of 
children to ascertain their HIV status was due to resource constraints within the MOH, and a lack of 
willingness by health workers to undertake testing due to stigma compounded by a lack of access 
to anti-retroviral therapy at the time of the study.  
 
Malawi, besides being a HIV high burden country, also has a high burden of TB.  A study carried 
out in Malawi of the case-load of the National TB Programme (NTP) in 1998 found 2,739 (11.9%) 
children 0-14 years of age with the majority 1,615 (7%) in the <5 years age group and had poor 
treatment outcomes.[28] Graham et al. in their study of 327 children admitted with severe and very 
severe pneumonia found 10 (3.1%) cases of TB, based on clinical assessment alone, 3 of which 
were already on TB treatment, and a further 35 (10.7%) children had a known household contact, 
20 of which were sputum smear-positive TB.[13] A number of studies from surrounding countries 
found that Mycobacterium tuberculosis was the underlying cause for pneumonia admissions in a 
high percentage of children.  In neighbouring Zambia Chintu et al. reported that Mycobacterium 
tuberculosis was the third most common autopsy finding (18.8%) in children dying from pneumonia 
irrespective of their HIV status.[29] Prospective clinical studies of South African children hospitalized 
with severe pneumonia confirmed TB as the cause in 7-8% of admissions.[30] McNally in a more 
recent study of South African children admitted with severe/very severe pneumonia (WHO-defined) 
found that 15% had culture-proven TB.[12] 
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Weismuller et al. in a study of the diagnosis of TB in children in Malawi found that diagnostic 
practices remained inadequate.[31] They found that in the majority of children with PTB that the 
diagnosis was based on a chest X-ray alone with other investigations, e.g. skin-testing, rarely 
performed due to the fact that only four hospitals had access to tuberculin skin test reagents.  Due 
to lack of testing of children to confirm their TB status at the district level due to resource 
constraints within the MOH meant that that the diagnosis of TB was not comprehensive in this 
group of patients. 
 
In this situation health workers need to be aware that if a child presents with persistent fever and 
signs of pneumonia and does not respond to antibiotics, they should evaluate the child for 
tuberculosis. The evaluation would include enquiring about recent close contact with a TB case 
and a chest X-ray as a minimum. This would be a challenge as chest X-rays and their 
interpretation are not widely available and few if any other diagnostic investigations are widely 
used outside sputum smear microscopy.  The diagnosis of TB can be suspected in the majority of 
children using careful clinical assessment. It is however difficult to confirm a diagnosis of childhood 
TB.  
  
It is recommended that at first referral level hospitals the staff should be trained to diagnose and 
initiate empirical treatment of uncomplicated tuberculosis in children. They should be able to 
recognise the symptoms and signs of probable tuberculosis, perform tuberculin skin tests and have 
access to a chest X-ray. All hospitalized children diagnosed with tuberculosis and commenced on 
TB treatment should be referred to the National Tuberculosis Programme and on discharge to 
continue treatment at the appropriate health centre.  It is also recommended that all children 
suspected of having TB should be tested for HIV.[32] 
 
The WHO antibiotic recommendations were made prior to the HIV era and have since been shown 
to be not as effective in HIV positive children with pneumonia. [12,18-20]  In high HIV/TB prevalent 
areas the management of pneumonia needs to be based on region/county specific knowledge of 
the wider spectrum of pathogens and antimicrobial resistance leading to a high failure rate.[20]  
 
It is recommended that bacterial aetiology and resistance studies be undertaken to inform high 
HIV-prevalent countries of the changes required in tailoring antibiotic use in standard case 
management (SCM) regimens. It is also recommended following the introduction of the H. 
influenzae type b and pneumococcal conjugate vaccine as they are likely to affect causes of 
bacterial pneumonia.[33] 
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Hypoxia is common in children with respiratory disease and is associated with significant morbidity 
and mortality, especially in young infants, those with very severe (hypoxic) pneumonia and PcP.  
There is clear evidence that oxygen therapy improves outcome in children with severe pneumonia, 
and that the routine use of oximetry improves identifying children requiring oxygen therapy as it is 
more sensitive and specific for identifying hypoxaemic children than clinical indicators.[34,35] As 
pulse oximetry was not routinely available during the study period the most hypoxaemic children 
were selected on clinical criteria for oxygen therapy. This is supported by the observation that 
mortality was higher in those that received oxygen, which likely reflects severity of disease rather 
than impact of oxygen.  This also meant that we could not calculate the direct impact oxygen had 
on the CFR.  The poor outcome in those receiving oxygen also suggests that PcP was not 
uncommon in this cohort.[14]  
 
Despite the fact that the CLHP had provided oxygen concentrators to all district hospital paediatric 
wards we found that oxygen had been used substantially less than expected, based on the annual 
number of very severe pneumonia admissions recorded for each hospital. One reason for this was 
the high attrition rate of staff that had been trained in the use and maintenance of the 
concentrators.  Another reason was that parents and guardians were reluctant for their children to 
receive oxygen therapy, as they believed their child could die once oxygen is administered.  Pulse 
oximeters may have assisted in actually showing parents the positive effects of oxygen therapy.  
 
A positive outcome of providing oxygen concentrators in the paediatric wards, capable of supplying 
oxygen to four children simultaneously, was that it resulted in the staff setting up a separate “high 
dependency” room or area within the pediatric ward where oxygen could be administered to a 
number severely ill children.  
 
This study found that comorbid conditions associated with an increased pneumonia-related 
mortality were malnutrition, severe anaemia and meningitis.  While none of these associations is 
unexpected, the unique characteristic of the study is that these factors have been analysed 
following prospective and complete clinical data collection from children managed under routine 
conditions at a district hospital level in a high mortality setting. A major limitation of the study is that 
the diagnosis of co-morbidities was usually clinical without laboratory confirmation for malaria, 
sepsis or severe anaemia. Therefore, it cannot be determined whether these conditions were 
under-diagnosed or over-diagnosed, especially as there is clinical overlap with severe pneumonia. 
Also while recognised as co-morbidities that can influence outcome, the evidence of association for 
this study is weakened by the lack of laboratory confirmation and objective measure of nutritional 
status such as weight-for-age. 
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Additional treatments, including oxygen, intravenous fluids or blood transfusion were all 
independently associated with a significantly higher CFR and are likely indicators of the severity of 
pneumonia and the presence of co-morbidities.  The poor outcome in those receiving oxygen also 
suggests that PcP was not uncommon in this cohort. 
 
Children that attended and received an antibiotic at a primary care facility prior to admission to the 
district hospital probably had more severe disease, and severity of disease was strongly 
associated with a poorer outcome.  We were not able to determine related issues of access to care 
such as distance from facilities, socio-economic or behavioural factors that determined use of care 
facilities or the duration of symptoms before presentation. 
 
Studies on quality of inpatient care of children with pneumonia have identified deficiencies, the 
main ones being poor case management including inadequate triage and assessment, over or 
under diagnosis of severe illness, and lack of implementation of appropriate guidelines for 
managing severe illness.[36] Other identified problems were over, under or inappropriate treatment 
with antibiotics, fluids and oxygen and lack of ongoing assessment/monitoring of the severely ill 
child.[8,37]  Problems identified within health systems included lack of appropriately trained health 
workers at all levels, insufficient level of staffing, poor supervision of staff, lack of quality assurance 
monitoring and insufficient supplies, drugs and equipment.[7]  The CLHP and oxygen system were 
development and implementation throughout Malawi to address these deficiencies as described in 
chapter 5a and 5b.  
 
This study was undertaken following training of health workers on standardised case management 
as well as ensuring provision of an uninterrupted supply of antibiotics and oxygen therapy. 
However, despite a one-week training course on SCM of pneumonia, follow-up and ongoing in-
service training, routine supervision and the introduction of mechanisms for quality assurance a 
large number of children were still incorrectly classified and therefore incorrectly treated.  Incorrect 
treatment was associated with an increased pneumonia-related mortality. 
 
The major challenge faced in the implementation of both of these programmes has been the 
chronic ongoing shortage of all categories of health care workers required to deliver quality health 
care and to maintain medical equipment. The attrition rate of trained workers has been high 
because of recruitment to the private sector, transfer of trained staff to other government hospitals, 
and deaths from HIV/AIDS.  Malawi experienced a six-fold increase in mortality of health workers 
from AIDS-related diseases between 1985 and 1997.[38] To address this challenge extra training 
courses, regular in-service and on-the-job training needed to be introduced for all categories of 
health-care workers. The MOH also increased the intake to nurses’ training institutes and restarted 
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the Medical Assistant training programme.  In 2007 Malawi health service vacancy levels remained 
static at 46% due to the continued high attrition rate and deaths which alone represented 50% of all 
trained staff losses.[39]   
This study has identified a number of reasons for poor pneumonia-related outcomes in young 
infants and children with very severe pneumonia.  First were several co-morbidities such as 
malaria, malnutrition, severe anaemia and HIV infection for which preventive measures to address 
these need to be introduced.  It also identified a number of potentially modifiable aspects of care 
where adjustments to the implementation of SCM are indicated.   
 
To improve the outcome of these children with pneumonia, organizational improvements are 
needed to address these needs.  
 
It is recommended that: 
 
1. Pulse oximetry should be introduced as it is an important tool to assess patient oxygen needs, 
instead of relying just on clinical signs. 
2. Pre-service training be introduced in institutions at all levels of health care workers to include 
correct classification of the severity of the disease and the use of correct antibiotics according 
to SCM of pneumonia. In addition, a more comprehensive training to deal with co-morbid 
conditions which might improve the quality of care.  
3. Regular supportive supervision of clinical and nursing staff, to monitor quality of care, be given 
high priority. 
4. First referral level hospitals staff should be trained to diagnose and initiate empirical treatment 
of uncomplicated tuberculosis in children. 
5. All children suspected of having TB should be tested for HIV 
6. Antibiotic regimens used in SCM of pneumonia be tailored to country specific pathogens and 
resistance patterns.. 
7. Universal testing for HIV, especially in pregnant women, be introduced 
8. The implementation of strategies that prevent HIV and Pneumocystis pneumonia be scaled-up 
9. More routine use of simple laboratory tests to detect malaria and anaemia   
 
Future research 
1. Research to evaluate the effect of the high dependency area on the quality of care and 
outcomes of children with very severe pneumonia. 
2. Research to determine related issues of access to care such as distance from facilities, socio-
economic or behavioural factors that determined use of care facilities and the duration of 
symptoms before presentation. 
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3. Research to investigate the process of transfer to hospital through the primary services  
4. Research to demonstrate how laboratory services could be more efficiently used to assist with 
diagnosis of pneumonia and co-morbidities. 
5. Aetiology studies to provide country specific pathogens and resistance patterns to inform 
antibiotic use.  
6. Research into the management of human resources in relation to staffing levels, length of 
rotation through paediatric ward and utilization of staff trained in the SCM of childhood illnesses 
and the effect on outcomes.  
7. Cost assessment study 
 
In conclusion, pneumonia-related mortality is common in Malawian infants and children cared for in 
the routine care hospital setting. It was possible to implement and sustain the CLHP in all district 
hospitals throughout the country.  Implementation of the CLHP was associated with a declining 
death rate among children aged two to fifty nine months with severe pneumonia.  Further reduction 
of mortality might be achieved through improved assessment, more rigorous application of 
standard case management and more accurate identification and effective management of co-
morbidities.   
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